{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":"Activist Defense","value":72},{"name":"Capital Markets","value":26},{"name":"Construction and Procurement","value":40},{"name":"Corporate Governance","value":27},{"name":"Emerging Companies and Venture Capital","value":80},{"name":"Employee Benefits and Executive Compensation","value":28},{"name":"Energy and Infrastructure Projects","value":35},{"name":"Financial Restructuring","value":10},{"name":"Fund Finance","value":134},{"name":"Global Human Capital and Compliance ","value":121},{"name":"Investment Funds and Asset Management","value":78},{"name":"Leveraged Finance","value":29},{"name":"Mergers and Acquisitions (M\u0026A)","value":32},{"name":"Middle East and Islamic Finance and Investment","value":31},{"name":"Private Equity","value":33},{"name":"Public Companies","value":126},{"name":"Real Estate","value":36},{"name":"Structured Finance and Securitization","value":82},{"name":"Tax","value":37},{"name":"Technology Transactions","value":115},{"name":"Government Matters","value":"cg-2"},{"name":"Antitrust","value":1},{"name":"Data, Privacy and Security","value":6},{"name":"Environmental, Health and Safety","value":71},{"name":"FDA and Life Sciences","value":21},{"name":"Government Advocacy and Public Policy","value":23},{"name":"Government Contracts","value":116},{"name":"Healthcare","value":24},{"name":"Innovation Protection","value":135},{"name":"International Trade","value":25},{"name":"National Security and Corporate Espionage","value":110},{"name":"Securities Enforcement and Regulation","value":20},{"name":"Special Matters and Government Investigations","value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":"Antitrust ","value":129},{"name":"Appellate, Constitutional and Administrative Law","value":2},{"name":"Bankruptcy and Insolvency Litigation","value":38},{"name":"Class Action Defense","value":3},{"name":"Commercial Litigation","value":5},{"name":"Corporate and Securities Litigation","value":19},{"name":"E-Discovery","value":7},{"name":"Global Construction and Infrastructure Disputes","value":4},{"name":"Innovation Protection","value":136},{"name":"Intellectual Property","value":13},{"name":"International Arbitration and Litigation","value":14},{"name":"Labor and Employment","value":15},{"name":"Product Liability","value":17},{"name":"Professional Liability","value":18},{"name":"Toxic \u0026 Environmental Torts","value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":"Artificial Intelligence (AI) and Machine Learning","value":133},{"name":"Automotive, Transportation and Mobility","value":106},{"name":"Buy American","value":124},{"name":"Crisis Management","value":111},{"name":"Doing Business in Latin America","value":132},{"name":"Energy Transition","value":131},{"name":"Energy","value":102},{"name":"Environmental Agenda","value":125},{"name":"Environmental, Social and Governance (ESG)","value":127},{"name":"Financial Services","value":107},{"name":"Focus on Women's Health","value":112},{"name":"Food and Beverage","value":105},{"name":"Higher Education","value":109},{"name":"Life Sciences and Healthcare","value":103},{"name":"Russia/Ukraine","value":128},{"name":"Special Purpose Acquisition Companies (SPACs)","value":123},{"name":"Technology","value":118}]},"title_id":null,"school_id":null,"office_id":"2","capability_id":null,"extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"K","per_page":12,"people":[{"id":441006,"version":1,"owner_type":"Person","owner_id":5652,"payload":{"bio":"\u003cp\u003eDaniel Kahan is partner in King \u0026amp; Spalding\u0026rsquo;s Corporate, Finance and Investments Practice and co-leads both the firm\u0026rsquo;s Emerging Companies and Venture Capital Group and Fintech Group. His corporate transactional practice focuses on private equity and venture capital investments, mergers and acquisitions, divestitures and spin-offs, debt and equity offerings, digital asset transactions, and corporate governance matters. Daniel also regularly advises clients in strategic technology and commercial transactions.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDaniel has worked with companies, entrepreneurs, private equity investors, venture capital investors, and strategic corporate investors and acquirers across a range of sectors, including enterprise software, artificial intelligence, fintech, blockchain, insurtech, cybersecurity, e-commerce, hardware, life sciences, healthcare, and travel.\u003c/p\u003e\n\u003cp\u003eDaniel is a frequent writer and speaker on startup, fintech, and digital asset topics.\u0026nbsp; He has been recognized by\u0026nbsp;\u003cem\u003eLegal 500\u003c/em\u003e\u0026nbsp;in its Venture Capital and Emerging Companies category, with clients describing him as a \u0026ldquo;best-in-class attorney\u0026rdquo; who is\u0026nbsp;\u0026ldquo;extremely knowledgeable, responsive, and efficient.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003e\u003cbr data-cke-eol=\"1\" /\u003e\u003cbr /\u003e\u003c/p\u003e","slug":"daniel-kahan","email":"dkahan@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":75,"guid":"75.capabilities","index":0,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":1,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":2,"source":"capabilities"},{"id":765,"guid":"765.smart_tags","index":3,"source":"smartTags"},{"id":115,"guid":"115.capabilities","index":4,"source":"capabilities"},{"id":1141,"guid":"1141.smart_tags","index":5,"source":"smartTags"},{"id":107,"guid":"107.capabilities","index":6,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":7,"source":"capabilities"},{"id":1192,"guid":"1192.smart_tags","index":8,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":9,"source":"capabilities"}],"is_active":true,"last_name":"Kahan","nick_name":"Daniel","clerkships":[],"first_name":"Daniel","title_rank":9999,"updated_by":202,"law_schools":[{"id":755,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2009-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"R.","name_suffix":"","recognitions":[{"title":"Circle of Excellence","detail":"Miami-Dade Bar, 2025"},{"title":"M\u0026A/Corporate and Commercial - Venture Capital \u0026 Emerging Companies","detail":"Legal 500, 2025"},{"title":"M\u0026A/Corporate and Commercial - Venture Capital \u0026 Emerging Companies","detail":"Legal 500, 2024"},{"title":"Florida Editorial Board","detail":"Law360, 2024"},{"title":"On the Rise Honoree","detail":"Daily Business Review Florida Legal Awards, 2024"},{"title":"40 Under 40 ","detail":"South Florida Business Journal, 2023"}],"linked_in_url":"https://www.linkedin.com/in/dankahan/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eDaniel Kahan is partner in King \u0026amp; Spalding\u0026rsquo;s Corporate, Finance and Investments Practice and co-leads both the firm\u0026rsquo;s Emerging Companies and Venture Capital Group and Fintech Group. His corporate transactional practice focuses on private equity and venture capital investments, mergers and acquisitions, divestitures and spin-offs, debt and equity offerings, digital asset transactions, and corporate governance matters. Daniel also regularly advises clients in strategic technology and commercial transactions.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDaniel has worked with companies, entrepreneurs, private equity investors, venture capital investors, and strategic corporate investors and acquirers across a range of sectors, including enterprise software, artificial intelligence, fintech, blockchain, insurtech, cybersecurity, e-commerce, hardware, life sciences, healthcare, and travel.\u003c/p\u003e\n\u003cp\u003eDaniel is a frequent writer and speaker on startup, fintech, and digital asset topics.\u0026nbsp; He has been recognized by\u0026nbsp;\u003cem\u003eLegal 500\u003c/em\u003e\u0026nbsp;in its Venture Capital and Emerging Companies category, with clients describing him as a \u0026ldquo;best-in-class attorney\u0026rdquo; who is\u0026nbsp;\u0026ldquo;extremely knowledgeable, responsive, and efficient.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003e\u003cbr data-cke-eol=\"1\" /\u003e\u003cbr /\u003e\u003c/p\u003e","recognitions":[{"title":"Circle of Excellence","detail":"Miami-Dade Bar, 2025"},{"title":"M\u0026A/Corporate and Commercial - Venture Capital \u0026 Emerging Companies","detail":"Legal 500, 2025"},{"title":"M\u0026A/Corporate and Commercial - Venture Capital \u0026 Emerging Companies","detail":"Legal 500, 2024"},{"title":"Florida Editorial Board","detail":"Law360, 2024"},{"title":"On the Rise Honoree","detail":"Daily Business Review Florida Legal Awards, 2024"},{"title":"40 Under 40 ","detail":"South Florida Business Journal, 2023"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":7443}]},"capability_group_id":1},"created_at":"2025-10-16T20:42:34.000Z","updated_at":"2025-10-16T20:42:34.000Z","searchable_text":"Kahan{{ FIELD }}{:title=\u0026gt;\"Circle of Excellence\", :detail=\u0026gt;\"Miami-Dade Bar, 2025\"}{{ FIELD }}{:title=\u0026gt;\"M\u0026amp;A/Corporate and Commercial - Venture Capital \u0026amp; Emerging Companies\", :detail=\u0026gt;\"Legal 500, 2025\"}{{ FIELD }}{:title=\u0026gt;\"M\u0026amp;A/Corporate and Commercial - Venture Capital \u0026amp; Emerging Companies\", :detail=\u0026gt;\"Legal 500, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Florida Editorial Board\", :detail=\u0026gt;\"Law360, 2024\"}{{ FIELD }}{:title=\u0026gt;\"On the Rise Honoree\", :detail=\u0026gt;\"Daily Business Review Florida Legal Awards, 2024\"}{{ FIELD }}{:title=\u0026gt;\"40 Under 40 \", :detail=\u0026gt;\"South Florida Business Journal, 2023\"}{{ FIELD }}Daniel Kahan is partner in King \u0026amp; Spalding’s Corporate, Finance and Investments Practice and co-leads both the firm’s Emerging Companies and Venture Capital Group and Fintech Group. His corporate transactional practice focuses on private equity and venture capital investments, mergers and acquisitions, divestitures and spin-offs, debt and equity offerings, digital asset transactions, and corporate governance matters. Daniel also regularly advises clients in strategic technology and commercial transactions. \nDaniel has worked with companies, entrepreneurs, private equity investors, venture capital investors, and strategic corporate investors and acquirers across a range of sectors, including enterprise software, artificial intelligence, fintech, blockchain, insurtech, cybersecurity, e-commerce, hardware, life sciences, healthcare, and travel.\nDaniel is a frequent writer and speaker on startup, fintech, and digital asset topics.  He has been recognized by Legal 500 in its Venture Capital and Emerging Companies category, with clients describing him as a “best-in-class attorney” who is “extremely knowledgeable, responsive, and efficient.”\n Partner Circle of Excellence Miami-Dade Bar, 2025 M\u0026amp;A/Corporate and Commercial - Venture Capital \u0026amp; Emerging Companies Legal 500, 2025 M\u0026amp;A/Corporate and Commercial - Venture Capital \u0026amp; Emerging Companies Legal 500, 2024 Florida Editorial Board Law360, 2024 On the Rise Honoree Daily Business Review Florida Legal Awards, 2024 40 Under 40  South Florida Business Journal, 2023 Georgetown University Georgetown University Law Center Georgetown University Georgetown University Law Center District of Columbia Florida Virginia","searchable_name":"Daniel R. Kahan","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442800,"version":1,"owner_type":"Person","owner_id":5640,"payload":{"bio":"\u003cp\u003eCharlie Katz is Managing Partner of King \u0026amp; Spalding\u0026rsquo;s Northern Virginia office.\u0026nbsp; He advises emerging growth and technology companies. On transactional work, Charlie\u0026nbsp;offers deep knowledge on mergers and acquisitions, private equity and venture capital transactions, divestitures, recapitalizations and restructurings, debt and equity financings and securities offerings, leveraged and management buyouts, joint ventures, and strategic investments.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIn these transactions, Charlie has represented the full range of parties, including bidders, targets, private equity groups, management teams, public companies, private companies, private investors, investment banks and financing sources. He has been involved in all phases of these transactions, including initial planning, structuring, negotiation, implementation and advice.\u003c/p\u003e\n\u003cp\u003eCharlie has worked on transactions across a variety of industries, including among others technology, government contractor, education, manufacturing, communications, and other regulated businesses. He has experience in both domestic and international transactions, including the representation of parties in cross-border transactions and with multinational investors.\u003c/p\u003e\n\u003cp\u003eClients look to Charlie on a broad range of corporate and securities and business-related matters, including directors' duties and responsibilities and other aspects of corporate governance and disclosure issues. He also has experience with transactions, financings, and corporate governance issues in financially distressed and bankruptcy situations.\u003c/p\u003e\n\u003cp\u003eIn 2025, he was top-ranked for Corporate/M\u0026amp;A by \u003cem\u003eChambers USA\u003c/em\u003e and is a recommended lawyer in M\u0026amp;A/Corporate and Commercial - Venture Capital \u0026amp; Emerging Companies by \u003cem\u003eLegal 500\u003c/em\u003e US. Legal 500 recognizes Charlie for being \u0026ldquo;an exceptional emerging company lawyer, with a deep understanding of the needs of emerging start-up technology companies.\u0026rdquo;\u003cem\u003e\u0026nbsp;\u003c/em\u003eCharlie has been ranked a leading corporate lawyer by \u003cem\u003eChambers USA\u003c/em\u003e since 2008 and has been recognized consistently by \u003cem\u003eBest Lawyers\u003c/em\u003e for Corporate Law. \u0026nbsp;A Chambers USA reviewer \u0026nbsp;described Charlie as \u0026ldquo;technically brilliant\u0026rdquo; and \u0026ldquo;well known in the market.\u0026rdquo; He is recognized for his \u0026ldquo;broad expertise in government contracting deals and M\u0026amp;A,\u0026rdquo; \u0026nbsp;and he is \u0026ldquo;highlighted for his expertise in technology and emerging growth businesses on both domestic and cross-border transactions.\u0026rdquo; Charlie was also recommended as a Top Lawyer in by the \u003cem\u003eWashington Business Journal\u003c/em\u003e.\u003c/p\u003e","slug":"charles-katz","email":"ckatz@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":75,"guid":"75.capabilities","index":0,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":1,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":2,"source":"capabilities"},{"id":27,"guid":"27.capabilities","index":3,"source":"capabilities"},{"id":10,"guid":"10.capabilities","index":4,"source":"capabilities"},{"id":29,"guid":"29.capabilities","index":5,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":6,"source":"capabilities"},{"id":1141,"guid":"1141.smart_tags","index":7,"source":"smartTags"},{"id":116,"guid":"116.capabilities","index":8,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":9,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":10,"source":"capabilities"},{"id":1147,"guid":"1147.smart_tags","index":11,"source":"smartTags"},{"id":124,"guid":"124.capabilities","index":12,"source":"capabilities"},{"id":126,"guid":"126.capabilities","index":13,"source":"capabilities"},{"id":1220,"guid":"1220.smart_tags","index":14,"source":"smartTags"},{"id":1270,"guid":"1270.smart_tags","index":15,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":16,"source":"capabilities"}],"is_active":true,"last_name":"Katz","nick_name":"Charles","clerkships":[],"first_name":"Charles","title_rank":9999,"updated_by":202,"law_schools":[{"id":2484,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"1992-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null},{"id":755,"meta":{"degree":"LL.M.","honors":"","is_law_school":"1","graduation_date":"1993-01-01 00:00:00"},"order":2,"pin_order":null,"pin_expiration":null}],"middle_name":"W.","name_suffix":"","recognitions":[{"title":"Top-ranked, Corporate/M\u0026A Northern Virginia","detail":"Chambers USA, 2025"},{"title":"Recommended Lawyer - M\u0026A/Corporate and Commercial - Venture Capital \u0026 Emerging Companies","detail":"Legal 500, 2025"},{"title":"Top-ranked - Corporate Law","detail":"Best Lawyers"}],"linked_in_url":null,"seodescription":null,"primary_title_id":132,"translated_fields":{"en":{"bio":"\u003cp\u003eCharlie Katz is Managing Partner of King \u0026amp; Spalding\u0026rsquo;s Northern Virginia office.\u0026nbsp; He advises emerging growth and technology companies. On transactional work, Charlie\u0026nbsp;offers deep knowledge on mergers and acquisitions, private equity and venture capital transactions, divestitures, recapitalizations and restructurings, debt and equity financings and securities offerings, leveraged and management buyouts, joint ventures, and strategic investments.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIn these transactions, Charlie has represented the full range of parties, including bidders, targets, private equity groups, management teams, public companies, private companies, private investors, investment banks and financing sources. He has been involved in all phases of these transactions, including initial planning, structuring, negotiation, implementation and advice.\u003c/p\u003e\n\u003cp\u003eCharlie has worked on transactions across a variety of industries, including among others technology, government contractor, education, manufacturing, communications, and other regulated businesses. He has experience in both domestic and international transactions, including the representation of parties in cross-border transactions and with multinational investors.\u003c/p\u003e\n\u003cp\u003eClients look to Charlie on a broad range of corporate and securities and business-related matters, including directors' duties and responsibilities and other aspects of corporate governance and disclosure issues. He also has experience with transactions, financings, and corporate governance issues in financially distressed and bankruptcy situations.\u003c/p\u003e\n\u003cp\u003eIn 2025, he was top-ranked for Corporate/M\u0026amp;A by \u003cem\u003eChambers USA\u003c/em\u003e and is a recommended lawyer in M\u0026amp;A/Corporate and Commercial - Venture Capital \u0026amp; Emerging Companies by \u003cem\u003eLegal 500\u003c/em\u003e US. Legal 500 recognizes Charlie for being \u0026ldquo;an exceptional emerging company lawyer, with a deep understanding of the needs of emerging start-up technology companies.\u0026rdquo;\u003cem\u003e\u0026nbsp;\u003c/em\u003eCharlie has been ranked a leading corporate lawyer by \u003cem\u003eChambers USA\u003c/em\u003e since 2008 and has been recognized consistently by \u003cem\u003eBest Lawyers\u003c/em\u003e for Corporate Law. \u0026nbsp;A Chambers USA reviewer \u0026nbsp;described Charlie as \u0026ldquo;technically brilliant\u0026rdquo; and \u0026ldquo;well known in the market.\u0026rdquo; He is recognized for his \u0026ldquo;broad expertise in government contracting deals and M\u0026amp;A,\u0026rdquo; \u0026nbsp;and he is \u0026ldquo;highlighted for his expertise in technology and emerging growth businesses on both domestic and cross-border transactions.\u0026rdquo; Charlie was also recommended as a Top Lawyer in by the \u003cem\u003eWashington Business Journal\u003c/em\u003e.\u003c/p\u003e","recognitions":[{"title":"Top-ranked, Corporate/M\u0026A Northern Virginia","detail":"Chambers USA, 2025"},{"title":"Recommended Lawyer - M\u0026A/Corporate and Commercial - Venture Capital \u0026 Emerging Companies","detail":"Legal 500, 2025"},{"title":"Top-ranked - Corporate Law","detail":"Best Lawyers"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":7303}]},"capability_group_id":1},"created_at":"2025-11-13T04:57:37.000Z","updated_at":"2025-11-13T04:57:37.000Z","searchable_text":"Katz{{ FIELD }}{:title=\u0026gt;\"Top-ranked, Corporate/M\u0026amp;A Northern Virginia\", :detail=\u0026gt;\"Chambers USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Lawyer - M\u0026amp;A/Corporate and Commercial - Venture Capital \u0026amp; Emerging Companies\", :detail=\u0026gt;\"Legal 500, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Top-ranked - Corporate Law\", :detail=\u0026gt;\"Best Lawyers\"}{{ FIELD }}Charlie Katz is Managing Partner of King \u0026amp; Spalding’s Northern Virginia office.  He advises emerging growth and technology companies. On transactional work, Charlie offers deep knowledge on mergers and acquisitions, private equity and venture capital transactions, divestitures, recapitalizations and restructurings, debt and equity financings and securities offerings, leveraged and management buyouts, joint ventures, and strategic investments.\nIn these transactions, Charlie has represented the full range of parties, including bidders, targets, private equity groups, management teams, public companies, private companies, private investors, investment banks and financing sources. He has been involved in all phases of these transactions, including initial planning, structuring, negotiation, implementation and advice.\nCharlie has worked on transactions across a variety of industries, including among others technology, government contractor, education, manufacturing, communications, and other regulated businesses. He has experience in both domestic and international transactions, including the representation of parties in cross-border transactions and with multinational investors.\nClients look to Charlie on a broad range of corporate and securities and business-related matters, including directors' duties and responsibilities and other aspects of corporate governance and disclosure issues. He also has experience with transactions, financings, and corporate governance issues in financially distressed and bankruptcy situations.\nIn 2025, he was top-ranked for Corporate/M\u0026amp;A by Chambers USA and is a recommended lawyer in M\u0026amp;A/Corporate and Commercial - Venture Capital \u0026amp; Emerging Companies by Legal 500 US. Legal 500 recognizes Charlie for being “an exceptional emerging company lawyer, with a deep understanding of the needs of emerging start-up technology companies.” Charlie has been ranked a leading corporate lawyer by Chambers USA since 2008 and has been recognized consistently by Best Lawyers for Corporate Law.  A Chambers USA reviewer  described Charlie as “technically brilliant” and “well known in the market.” He is recognized for his “broad expertise in government contracting deals and M\u0026amp;A,”  and he is “highlighted for his expertise in technology and emerging growth businesses on both domestic and cross-border transactions.” Charlie was also recommended as a Top Lawyer in by the Washington Business Journal. Partner Top-ranked, Corporate/M\u0026amp;A Northern Virginia Chambers USA, 2025 Recommended Lawyer - M\u0026amp;A/Corporate and Commercial - Venture Capital \u0026amp; Emerging Companies Legal 500, 2025 Top-ranked - Corporate Law Best Lawyers Lafayette College  Washington and Lee University Washington and Lee University School of Law Georgetown University Georgetown University Law Center District of Columbia Virginia American Bar Association (1998, Member# 01209087)","searchable_name":"Charles W. Katz","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426909,"version":1,"owner_type":"Person","owner_id":5930,"payload":{"bio":"\u003cp\u003eAlexander Kazam is a partner\u0026nbsp;in the Washington, D.C. office of King \u0026amp; Spalding and a member of the firm\u0026rsquo;s Appellate, Constitutional, and Administrative Law practice group.\u0026nbsp; Alex\u0026rsquo;s practice focuses on appeals, dispositive motions, and counseling clients on high-stakes legal issues.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePreviously, Alex\u0026nbsp;served as senior counsel in the Office of the Associate Attorney General at the United States Department of Justice, where he assisted in supervising the Department\u0026rsquo;s civil litigation and drafted public addresses for the Attorney General of the United States.\u0026nbsp; Alex\u0026nbsp;has also clerked at every level of the federal judiciary: for Justices Neil M. Gorsuch and Anthony M. Kennedy of the United States Supreme Court; for Judge Raymond M. Kethledge of the United States Court of Appeals for the Sixth Circuit; and for Judge Richard J. Sullivan of the United States District Court for the Southern District of New York.\u003c/p\u003e","slug":"alexander-kazam","email":"akazam@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":1,"source":"capabilities"}],"is_active":true,"last_name":"Kazam","nick_name":"Alexander","clerkships":[{"name":"Law Clerk, Justice Neil M. Gorsuch, Supreme Court of the United States","years_held":"2018 - 2019"},{"name":"Law Clerk, Judge Raymond M. Kethledge, U.S. Court of Appeals for the Sixth Circuit","years_held":"2016 - 2017"},{"name":"Law Clerk, Judge Richard J. Sullivan, U.S. District Court for the Southern District of New York","years_held":"2017 - 2018"}],"first_name":"Alexander","title_rank":9999,"updated_by":32,"law_schools":[{"id":2605,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2016-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAlexander Kazam is a partner\u0026nbsp;in the Washington, D.C. office of King \u0026amp; Spalding and a member of the firm\u0026rsquo;s Appellate, Constitutional, and Administrative Law practice group.\u0026nbsp; Alex\u0026rsquo;s practice focuses on appeals, dispositive motions, and counseling clients on high-stakes legal issues.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePreviously, Alex\u0026nbsp;served as senior counsel in the Office of the Associate Attorney General at the United States Department of Justice, where he assisted in supervising the Department\u0026rsquo;s civil litigation and drafted public addresses for the Attorney General of the United States.\u0026nbsp; Alex\u0026nbsp;has also clerked at every level of the federal judiciary: for Justices Neil M. Gorsuch and Anthony M. Kennedy of the United States Supreme Court; for Judge Raymond M. Kethledge of the United States Court of Appeals for the Sixth Circuit; and for Judge Richard J. Sullivan of the United States District Court for the Southern District of New York.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10794}]},"capability_group_id":3},"created_at":"2025-05-26T04:57:45.000Z","updated_at":"2025-05-26T04:57:45.000Z","searchable_text":"Kazam{{ FIELD }}Alexander Kazam is a partner in the Washington, D.C. office of King \u0026amp; Spalding and a member of the firm’s Appellate, Constitutional, and Administrative Law practice group.  Alex’s practice focuses on appeals, dispositive motions, and counseling clients on high-stakes legal issues.\nPreviously, Alex served as senior counsel in the Office of the Associate Attorney General at the United States Department of Justice, where he assisted in supervising the Department’s civil litigation and drafted public addresses for the Attorney General of the United States.  Alex has also clerked at every level of the federal judiciary: for Justices Neil M. Gorsuch and Anthony M. Kennedy of the United States Supreme Court; for Judge Raymond M. Kethledge of the United States Court of Appeals for the Sixth Circuit; and for Judge Richard J. Sullivan of the United States District Court for the Southern District of New York. Partner Harvard University Harvard Law School Yale University Yale Law School U.S. Court of Appeals for the Federal Circuit Supreme Court of the United States U.S. Court of Appeals for the First Circuit U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Third Circuit U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Fifth Circuit U.S. Court of Appeals for the Sixth Circuit U.S. Court of Appeals for the Seventh Circuit U.S. Court of Appeals for the Eighth Circuit U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the Eleventh Circuit District of Columbia New York Law Clerk, Justice Neil M. Gorsuch, Supreme Court of the United States Law Clerk, Judge Raymond M. Kethledge, U.S. Court of Appeals for the Sixth Circuit Law Clerk, Judge Richard J. Sullivan, U.S. District Court for the Southern District of New York","searchable_name":"Alexander Kazam","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":445387,"version":1,"owner_type":"Person","owner_id":2473,"payload":{"bio":"\u003cp\u003eChris Kenny is a partner in our Healthcare practice and specializes in providing strategic payment and compliance advice to hospitals, health systems, academic medical centers, and other organizations participating in Medicare, Medicaid and commercial insurance plans.\u0026nbsp; For the past nine years, Chris has been recognized by \u003cem\u003eChambers USA\u003c/em\u003e as a leading healthcare lawyer and in 2020 was named a Top Attorney Under 40 by\u0026nbsp;\u003cem\u003eLaw 360\u003c/em\u003e.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith in-depth knowledge of payment systems and regulations, Chris\u0026nbsp;regularly advises in-house lawyers and C-suite executives on the payment implications of major business decisions including facility construction/acquisition,\u0026nbsp;medical staff relations, the operation\u0026nbsp;and expansion of graduate medical education and allied health training programs,\u0026nbsp;organ acquisition program management, participation in the 340B Drug Pricing Program,\u0026nbsp;and telehealth expansion.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eApplying his regulatory and reimbursement experience, Chris represents hospitals in Medicare payment litigation\u0026nbsp;and before Congress and the administrative branch, as well as in\u0026nbsp;False Claims Act investigations by the U.S. Department of Justice.\u003c/p\u003e\n\u003cp\u003eHe strives to provide creative, proactive advice in an ever-changing healthcare regulatory environment, and to vigorously defend his clients\u0026rsquo; positions in payment disputes and government investigations.\u003c/p\u003e\n\u003cp\u003eA member of the Healthcare Financial Management Association and the American Health Lawyers Association, Chris regularly speaks and writes on reimbursement and compliance issues. He is the co-editor of the \u003cem\u003eReimbursement Advisor,\u003c/em\u003e the leading national healthcare reimbursement publication, and serves as co-editor of our firm\u0026rsquo;s award-winning \u003cem\u003eHealth Headlines\u003c/em\u003e, a weekly newsletter summarizing healthcare law and policy developments.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eADMITTED TO PRACTICE IN DISTRICT OF COLUMBIA AND MARYLAND; NOT ADMITTED TO PRACTICE IN FLORIDA\u003c/strong\u003e\u003c/p\u003e","slug":"christopher-kenny","email":"ckenny@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented the Florida Hospital Association and 12 of its members in a precedent-setting challenge to CMS's exclusion of section 1115 waiver days from the Medicare DSH payment adjustment, resulting in a multi-million dollar victory.\u0026nbsp;\u003cem\u003eSee Bethesda Health v. Azar\u003c/em\u003e, 980 F.3d 121 (D.C. Cir. 2020). Mr. Kenny is currently pursuing the same issue on behalf of dozens more hospitals in Florida, Texas, California, Tennessee and elsewhere, with total amounts in controversy worth hundreds of millions of dollars.\u003c/p\u003e","\u003cp\u003eRepresented 34 hospitals in overturning CMS's unlawful policy understating the so-called \"rural floor,\" generating hundreds of millions of dollars in additional wage-related payments for providers in Arizona, Connecticut, Florida, and elsewhere.\u0026nbsp;\u003cem\u003eCitrus HMA v. Azar\u003c/em\u003e, Case No. 20-00707, 2022 WL 1062990 (D.D.C. 2022).\u003c/p\u003e","\u003cp\u003eSuccessfully represented five major health systems in overturning CMS's disallowance of millions of dollars in financial support for the hospitals' nursing and other training programs. The court noted \"the hosptials are right, and it is not even close.\"\u0026nbsp;\u003cem\u003eMercy Health-St. Vincent Medical Center v. Becerra\u003c/em\u003e, Case No. 22-3578 (D.D.C. 2024).\u003c/p\u003e","\u003cp\u003eRegularly provides day-to-day counseling to more than a dozen major health systems in the establishment and operation of large outpatient provider-based facilities and rural health clinics. Issues involved include the structuring of complex management agreements, joint ventures, 340B considerations, service line collaborations, and hospital-physician relationships.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a Medicaid managed care organization in multiple False Claims Act investigations by local U.S. Attorneys' Offices resulting in declinations.\u003c/p\u003e","\u003cp\u003eRecovered millions of dollars in additional cost reimbursement for an organ procurement organization's clinical laboratory activities.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":116}]},"expertise":[{"id":103,"guid":"103.capabilities","index":0,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":1,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":2,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":3,"source":"capabilities"},{"id":12,"guid":"12.capabilities","index":4,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":5,"source":"capabilities"},{"id":826,"guid":"826.smart_tags","index":6,"source":"smartTags"},{"id":114,"guid":"114.capabilities","index":7,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":8,"source":"capabilities"},{"id":1185,"guid":"1185.smart_tags","index":9,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Kenny","nick_name":"Chris","clerkships":[],"first_name":"Christopher","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"P.","name_suffix":"","recognitions":[{"title":"2020 Top Attorneys Under 40 - Healthcare","detail":"Law360"},{"title":"Ranked in Chambers USA for Healthcare 2017-2021","detail":"Chambers USA"},{"title":"Named a Rising Star in Healthcare","detail":"SUPER LAWYERS, 2018"},{"title":"Named a Rising Star in Healthcare","detail":"Super Lawyers, 2017"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eChris Kenny is a partner in our Healthcare practice and specializes in providing strategic payment and compliance advice to hospitals, health systems, academic medical centers, and other organizations participating in Medicare, Medicaid and commercial insurance plans.\u0026nbsp; For the past nine years, Chris has been recognized by \u003cem\u003eChambers USA\u003c/em\u003e as a leading healthcare lawyer and in 2020 was named a Top Attorney Under 40 by\u0026nbsp;\u003cem\u003eLaw 360\u003c/em\u003e.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith in-depth knowledge of payment systems and regulations, Chris\u0026nbsp;regularly advises in-house lawyers and C-suite executives on the payment implications of major business decisions including facility construction/acquisition,\u0026nbsp;medical staff relations, the operation\u0026nbsp;and expansion of graduate medical education and allied health training programs,\u0026nbsp;organ acquisition program management, participation in the 340B Drug Pricing Program,\u0026nbsp;and telehealth expansion.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eApplying his regulatory and reimbursement experience, Chris represents hospitals in Medicare payment litigation\u0026nbsp;and before Congress and the administrative branch, as well as in\u0026nbsp;False Claims Act investigations by the U.S. Department of Justice.\u003c/p\u003e\n\u003cp\u003eHe strives to provide creative, proactive advice in an ever-changing healthcare regulatory environment, and to vigorously defend his clients\u0026rsquo; positions in payment disputes and government investigations.\u003c/p\u003e\n\u003cp\u003eA member of the Healthcare Financial Management Association and the American Health Lawyers Association, Chris regularly speaks and writes on reimbursement and compliance issues. He is the co-editor of the \u003cem\u003eReimbursement Advisor,\u003c/em\u003e the leading national healthcare reimbursement publication, and serves as co-editor of our firm\u0026rsquo;s award-winning \u003cem\u003eHealth Headlines\u003c/em\u003e, a weekly newsletter summarizing healthcare law and policy developments.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eADMITTED TO PRACTICE IN DISTRICT OF COLUMBIA AND MARYLAND; NOT ADMITTED TO PRACTICE IN FLORIDA\u003c/strong\u003e\u003c/p\u003e","matters":["\u003cp\u003eRepresented the Florida Hospital Association and 12 of its members in a precedent-setting challenge to CMS's exclusion of section 1115 waiver days from the Medicare DSH payment adjustment, resulting in a multi-million dollar victory.\u0026nbsp;\u003cem\u003eSee Bethesda Health v. Azar\u003c/em\u003e, 980 F.3d 121 (D.C. Cir. 2020). Mr. Kenny is currently pursuing the same issue on behalf of dozens more hospitals in Florida, Texas, California, Tennessee and elsewhere, with total amounts in controversy worth hundreds of millions of dollars.\u003c/p\u003e","\u003cp\u003eRepresented 34 hospitals in overturning CMS's unlawful policy understating the so-called \"rural floor,\" generating hundreds of millions of dollars in additional wage-related payments for providers in Arizona, Connecticut, Florida, and elsewhere.\u0026nbsp;\u003cem\u003eCitrus HMA v. Azar\u003c/em\u003e, Case No. 20-00707, 2022 WL 1062990 (D.D.C. 2022).\u003c/p\u003e","\u003cp\u003eSuccessfully represented five major health systems in overturning CMS's disallowance of millions of dollars in financial support for the hospitals' nursing and other training programs. The court noted \"the hosptials are right, and it is not even close.\"\u0026nbsp;\u003cem\u003eMercy Health-St. Vincent Medical Center v. Becerra\u003c/em\u003e, Case No. 22-3578 (D.D.C. 2024).\u003c/p\u003e","\u003cp\u003eRegularly provides day-to-day counseling to more than a dozen major health systems in the establishment and operation of large outpatient provider-based facilities and rural health clinics. Issues involved include the structuring of complex management agreements, joint ventures, 340B considerations, service line collaborations, and hospital-physician relationships.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a Medicaid managed care organization in multiple False Claims Act investigations by local U.S. Attorneys' Offices resulting in declinations.\u003c/p\u003e","\u003cp\u003eRecovered millions of dollars in additional cost reimbursement for an organ procurement organization's clinical laboratory activities.\u003c/p\u003e"],"recognitions":[{"title":"2020 Top Attorneys Under 40 - Healthcare","detail":"Law360"},{"title":"Ranked in Chambers USA for Healthcare 2017-2021","detail":"Chambers USA"},{"title":"Named a Rising Star in Healthcare","detail":"SUPER LAWYERS, 2018"},{"title":"Named a Rising Star in Healthcare","detail":"Super Lawyers, 2017"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10000}]},"capability_group_id":2},"created_at":"2026-01-30T19:46:10.000Z","updated_at":"2026-01-30T19:46:10.000Z","searchable_text":"Kenny{{ FIELD }}{:title=\u0026gt;\"2020 Top Attorneys Under 40 - Healthcare\", :detail=\u0026gt;\"Law360\"}{{ FIELD }}{:title=\u0026gt;\"Ranked in Chambers USA for Healthcare 2017-2021\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Named a Rising Star in Healthcare\", :detail=\u0026gt;\"SUPER LAWYERS, 2018\"}{{ FIELD }}{:title=\u0026gt;\"Named a Rising Star in Healthcare\", :detail=\u0026gt;\"Super Lawyers, 2017\"}{{ FIELD }}Represented the Florida Hospital Association and 12 of its members in a precedent-setting challenge to CMS's exclusion of section 1115 waiver days from the Medicare DSH payment adjustment, resulting in a multi-million dollar victory. See Bethesda Health v. Azar, 980 F.3d 121 (D.C. Cir. 2020). Mr. Kenny is currently pursuing the same issue on behalf of dozens more hospitals in Florida, Texas, California, Tennessee and elsewhere, with total amounts in controversy worth hundreds of millions of dollars.{{ FIELD }}Represented 34 hospitals in overturning CMS's unlawful policy understating the so-called \"rural floor,\" generating hundreds of millions of dollars in additional wage-related payments for providers in Arizona, Connecticut, Florida, and elsewhere. Citrus HMA v. Azar, Case No. 20-00707, 2022 WL 1062990 (D.D.C. 2022).{{ FIELD }}Successfully represented five major health systems in overturning CMS's disallowance of millions of dollars in financial support for the hospitals' nursing and other training programs. The court noted \"the hosptials are right, and it is not even close.\" Mercy Health-St. Vincent Medical Center v. Becerra, Case No. 22-3578 (D.D.C. 2024).{{ FIELD }}Regularly provides day-to-day counseling to more than a dozen major health systems in the establishment and operation of large outpatient provider-based facilities and rural health clinics. Issues involved include the structuring of complex management agreements, joint ventures, 340B considerations, service line collaborations, and hospital-physician relationships.{{ FIELD }}Successfully represented a Medicaid managed care organization in multiple False Claims Act investigations by local U.S. Attorneys' Offices resulting in declinations.{{ FIELD }}Recovered millions of dollars in additional cost reimbursement for an organ procurement organization's clinical laboratory activities.{{ FIELD }}Chris Kenny is a partner in our Healthcare practice and specializes in providing strategic payment and compliance advice to hospitals, health systems, academic medical centers, and other organizations participating in Medicare, Medicaid and commercial insurance plans.  For the past nine years, Chris has been recognized by Chambers USA as a leading healthcare lawyer and in 2020 was named a Top Attorney Under 40 by Law 360.\nWith in-depth knowledge of payment systems and regulations, Chris regularly advises in-house lawyers and C-suite executives on the payment implications of major business decisions including facility construction/acquisition, medical staff relations, the operation and expansion of graduate medical education and allied health training programs, organ acquisition program management, participation in the 340B Drug Pricing Program, and telehealth expansion.  \nApplying his regulatory and reimbursement experience, Chris represents hospitals in Medicare payment litigation and before Congress and the administrative branch, as well as in False Claims Act investigations by the U.S. Department of Justice.\nHe strives to provide creative, proactive advice in an ever-changing healthcare regulatory environment, and to vigorously defend his clients’ positions in payment disputes and government investigations.\nA member of the Healthcare Financial Management Association and the American Health Lawyers Association, Chris regularly speaks and writes on reimbursement and compliance issues. He is the co-editor of the Reimbursement Advisor, the leading national healthcare reimbursement publication, and serves as co-editor of our firm’s award-winning Health Headlines, a weekly newsletter summarizing healthcare law and policy developments.\nADMITTED TO PRACTICE IN DISTRICT OF COLUMBIA AND MARYLAND; NOT ADMITTED TO PRACTICE IN FLORIDA Christopher P Kenny Partner 2020 Top Attorneys Under 40 - Healthcare Law360 Ranked in Chambers USA for Healthcare 2017-2021 Chambers USA Named a Rising Star in Healthcare SUPER LAWYERS, 2018 Named a Rising Star in Healthcare Super Lawyers, 2017 Northwestern University Northwestern Pritzker School of Law George Washington University George Washington University Law School U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the District of Columbia District of Columbia Maryland American Health Lawyers Association Healthcare Financial Management Association Represented the Florida Hospital Association and 12 of its members in a precedent-setting challenge to CMS's exclusion of section 1115 waiver days from the Medicare DSH payment adjustment, resulting in a multi-million dollar victory. See Bethesda Health v. Azar, 980 F.3d 121 (D.C. Cir. 2020). Mr. Kenny is currently pursuing the same issue on behalf of dozens more hospitals in Florida, Texas, California, Tennessee and elsewhere, with total amounts in controversy worth hundreds of millions of dollars. Represented 34 hospitals in overturning CMS's unlawful policy understating the so-called \"rural floor,\" generating hundreds of millions of dollars in additional wage-related payments for providers in Arizona, Connecticut, Florida, and elsewhere. Citrus HMA v. Azar, Case No. 20-00707, 2022 WL 1062990 (D.D.C. 2022). Successfully represented five major health systems in overturning CMS's disallowance of millions of dollars in financial support for the hospitals' nursing and other training programs. The court noted \"the hosptials are right, and it is not even close.\" Mercy Health-St. Vincent Medical Center v. Becerra, Case No. 22-3578 (D.D.C. 2024). Regularly provides day-to-day counseling to more than a dozen major health systems in the establishment and operation of large outpatient provider-based facilities and rural health clinics. Issues involved include the structuring of complex management agreements, joint ventures, 340B considerations, service line collaborations, and hospital-physician relationships. Successfully represented a Medicaid managed care organization in multiple False Claims Act investigations by local U.S. Attorneys' Offices resulting in declinations. Recovered millions of dollars in additional cost reimbursement for an organ procurement organization's clinical laboratory activities.","searchable_name":"Christopher P. Kenny (Chris)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":445251,"version":1,"owner_type":"Person","owner_id":7300,"payload":{"bio":"\u003cp\u003eCat Kirkland is based in Washington, D.C. and is a partner in the firm\u0026rsquo;s Healthcare practice. Cat works closely with hospitals, providers and related stakeholders on reimbursement issues, policy development, financial modeling and business operations. Known for her collaborative, solution-oriented approach, Cat thrives on becoming a trusted partner for each client and takes pride in helping providers navigate challenging and complex legal and reimbursement environments.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eCat\u0026rsquo;s reimbursement experience includes advising clients on state-directed payment initiatives, Medicaid rate modeling, program financing, disproportionate share hospital (DSH) programs, upper payment limit (UPL) arrangements and value-based or incentive-driven payment models. She also regularly counsels providers in reimbursement disputes with commercial and Medicare Advantage payors, including those involving the 340B Drug Pricing Program.\u003c/p\u003e\n\u003cp\u003eOutside the office, Cat enjoys spending time with her husband and three children, traveling and volunteering in her community.\u003c/p\u003e","slug":"catherine-kirkland","email":"ckirkland@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented a children\u0026rsquo;s hospital in Medicaid reimbursement strategy, leading advocacy and financial modeling efforts that secured inclusion of the hospital in a supplemental Medicaid program through a regulatory exception, resulting in substantial new funding for the hospital.\u003c/p\u003e","\u003cp\u003eRepresented group of hospitals in the development of complex Medicaid financial models and strategic advocacy to support expansion of a directed payment program to a new beneficiary population, resulting in significant new funding for participating providers throughout the state.\u003c/p\u003e","\u003cp\u003eConducted comprehensive Medicaid market analyses for psychiatric hospitals entering new state footprints, assessing potential financial impact and reimbursement opportunities. Provided private equity clients with data-driven insights and modeling to inform investment decisions and strategy for expansion.\u003c/p\u003e","\u003cp\u003eRepresented a large healthcare system in arbitration against a national Medicare Advantage plan resulting in a decisive win and significant financial recovery for the system.\u003c/p\u003e","\u003cp\u003eRegularly analyze and prepare Medicaid DSH applications and audits, identifying new funding opportunities for clients and assisting in averting potential recoupments.\u003c/p\u003e","\u003cp\u003eAssisted clients in modeling the Medicaid financial impact of the One Big Beautiful Bill, developing a variety of scenarios to consider financing, projected payments, and potential operational changes. Provided actionable insights to help clients plan strategically and adapt to evolving policy and market conditions.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":826,"guid":"826.smart_tags","index":3,"source":"smartTags"},{"id":740,"guid":"740.smart_tags","index":4,"source":"smartTags"}],"is_active":true,"last_name":"Kirkland","nick_name":"Cat","clerkships":[],"first_name":"Catherine","title_rank":9999,"updated_by":34,"law_schools":[{"id":2055,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2011-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/catherine-stanford-kirkland-a074b055/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eCat Kirkland is based in Washington, D.C. and is a partner in the firm\u0026rsquo;s Healthcare practice. Cat works closely with hospitals, providers and related stakeholders on reimbursement issues, policy development, financial modeling and business operations. Known for her collaborative, solution-oriented approach, Cat thrives on becoming a trusted partner for each client and takes pride in helping providers navigate challenging and complex legal and reimbursement environments.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eCat\u0026rsquo;s reimbursement experience includes advising clients on state-directed payment initiatives, Medicaid rate modeling, program financing, disproportionate share hospital (DSH) programs, upper payment limit (UPL) arrangements and value-based or incentive-driven payment models. She also regularly counsels providers in reimbursement disputes with commercial and Medicare Advantage payors, including those involving the 340B Drug Pricing Program.\u003c/p\u003e\n\u003cp\u003eOutside the office, Cat enjoys spending time with her husband and three children, traveling and volunteering in her community.\u003c/p\u003e","matters":["\u003cp\u003eRepresented a children\u0026rsquo;s hospital in Medicaid reimbursement strategy, leading advocacy and financial modeling efforts that secured inclusion of the hospital in a supplemental Medicaid program through a regulatory exception, resulting in substantial new funding for the hospital.\u003c/p\u003e","\u003cp\u003eRepresented group of hospitals in the development of complex Medicaid financial models and strategic advocacy to support expansion of a directed payment program to a new beneficiary population, resulting in significant new funding for participating providers throughout the state.\u003c/p\u003e","\u003cp\u003eConducted comprehensive Medicaid market analyses for psychiatric hospitals entering new state footprints, assessing potential financial impact and reimbursement opportunities. Provided private equity clients with data-driven insights and modeling to inform investment decisions and strategy for expansion.\u003c/p\u003e","\u003cp\u003eRepresented a large healthcare system in arbitration against a national Medicare Advantage plan resulting in a decisive win and significant financial recovery for the system.\u003c/p\u003e","\u003cp\u003eRegularly analyze and prepare Medicaid DSH applications and audits, identifying new funding opportunities for clients and assisting in averting potential recoupments.\u003c/p\u003e","\u003cp\u003eAssisted clients in modeling the Medicaid financial impact of the One Big Beautiful Bill, developing a variety of scenarios to consider financing, projected payments, and potential operational changes. Provided actionable insights to help clients plan strategically and adapt to evolving policy and market conditions.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13319}]},"capability_group_id":2},"created_at":"2026-01-26T14:43:19.000Z","updated_at":"2026-01-26T14:43:19.000Z","searchable_text":"Kirkland{{ FIELD }}Represented a children’s hospital in Medicaid reimbursement strategy, leading advocacy and financial modeling efforts that secured inclusion of the hospital in a supplemental Medicaid program through a regulatory exception, resulting in substantial new funding for the hospital.{{ FIELD }}Represented group of hospitals in the development of complex Medicaid financial models and strategic advocacy to support expansion of a directed payment program to a new beneficiary population, resulting in significant new funding for participating providers throughout the state.{{ FIELD }}Conducted comprehensive Medicaid market analyses for psychiatric hospitals entering new state footprints, assessing potential financial impact and reimbursement opportunities. Provided private equity clients with data-driven insights and modeling to inform investment decisions and strategy for expansion.{{ FIELD }}Represented a large healthcare system in arbitration against a national Medicare Advantage plan resulting in a decisive win and significant financial recovery for the system.{{ FIELD }}Regularly analyze and prepare Medicaid DSH applications and audits, identifying new funding opportunities for clients and assisting in averting potential recoupments.{{ FIELD }}Assisted clients in modeling the Medicaid financial impact of the One Big Beautiful Bill, developing a variety of scenarios to consider financing, projected payments, and potential operational changes. Provided actionable insights to help clients plan strategically and adapt to evolving policy and market conditions.{{ FIELD }}Cat Kirkland is based in Washington, D.C. and is a partner in the firm’s Healthcare practice. Cat works closely with hospitals, providers and related stakeholders on reimbursement issues, policy development, financial modeling and business operations. Known for her collaborative, solution-oriented approach, Cat thrives on becoming a trusted partner for each client and takes pride in helping providers navigate challenging and complex legal and reimbursement environments.\nCat’s reimbursement experience includes advising clients on state-directed payment initiatives, Medicaid rate modeling, program financing, disproportionate share hospital (DSH) programs, upper payment limit (UPL) arrangements and value-based or incentive-driven payment models. She also regularly counsels providers in reimbursement disputes with commercial and Medicare Advantage payors, including those involving the 340B Drug Pricing Program.\nOutside the office, Cat enjoys spending time with her husband and three children, traveling and volunteering in her community. Partner The University of Texas at Austin The University of Texas School of Law The University of Texas at Austin The University of Texas School of Law Alabama Texas Texas Bar Association The American Health Lawyers Association Mobile Bar Association Represented a children’s hospital in Medicaid reimbursement strategy, leading advocacy and financial modeling efforts that secured inclusion of the hospital in a supplemental Medicaid program through a regulatory exception, resulting in substantial new funding for the hospital. Represented group of hospitals in the development of complex Medicaid financial models and strategic advocacy to support expansion of a directed payment program to a new beneficiary population, resulting in significant new funding for participating providers throughout the state. Conducted comprehensive Medicaid market analyses for psychiatric hospitals entering new state footprints, assessing potential financial impact and reimbursement opportunities. Provided private equity clients with data-driven insights and modeling to inform investment decisions and strategy for expansion. Represented a large healthcare system in arbitration against a national Medicare Advantage plan resulting in a decisive win and significant financial recovery for the system. Regularly analyze and prepare Medicaid DSH applications and audits, identifying new funding opportunities for clients and assisting in averting potential recoupments. Assisted clients in modeling the Medicaid financial impact of the One Big Beautiful Bill, developing a variety of scenarios to consider financing, projected payments, and potential operational changes. Provided actionable insights to help clients plan strategically and adapt to evolving policy and market conditions.","searchable_name":"Catherine Kirkland (Cat)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":34,"capability_group_featured":null,"home_page_featured":null},{"id":440298,"version":1,"owner_type":"Person","owner_id":2100,"payload":{"bio":"\u003cp\u003eAmanda Klingler is a partner in the firm\u0026rsquo;s Washington, D.C. and Chicago offices with extensive experience advising life science clients.\u0026nbsp; As a partner in the firm's FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAmanda counsels clients on pre- and post-marketing regulatory activities and strategies, including obtaining FDA approval and clearance for medical products.\u0026nbsp; Amanda also regularly advises clients on product labeling, adverse event reporting, product safety issues, recalls/field corrections, import detention, and advertising and promotion issues.\u0026nbsp; She counsels clients on quality system and manufacturing practices for drugs and medical devices and factory inspections, including conducting mock inspections and working closely with and providing advice to clients during the inspection, and provide guidance in responding to FDA investigational observations (FDA-483 forms), and warning letters.\u0026nbsp;\u0026nbsp;Amanda, as a co-leader of the firm\u0026rsquo;s AI/ML Tactical Operations team, also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAmanda advises clients during internal and government investigations.\u0026nbsp; She also assists in the negotiation and management of several consent decrees of injunction for pharmaceutical, medical device, food companies and compounding pharmacies.\u003c/p\u003e\n\u003cp\u003eAmanda works closely with the firm's product liability team and is experienced in handling FDA issues in product liability litigation, including the development of supporting evidence, writing briefs, and preparing expert witnesses to testify.\u003c/p\u003e\n\u003cp\u003eAmanda also has significant experience and expertise in FDA's regulation of tobacco products.\u003c/p\u003e","slug":"amanda-klingler","email":"aklingler@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cem\u003ePhillips Morris USA v. FDA,\u0026nbsp;\u003c/em\u003e202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eproduct liability litigation\u003c/strong\u003einvolving GlaxoSmithKline\u0026rsquo;s antidepressant Paxil\u0026reg;, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003ein limine\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003eDaubert\u003c/em\u003echallenges.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team representing the\u0026nbsp;\u003cstrong\u003emanufacturer of FDA-cleared surgical gowns\u0026nbsp;\u003c/strong\u003ein nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a\u0026nbsp;\u003cem\u003equi tam\u0026nbsp;\u003c/em\u003esuit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ecompanies in preparing for FDA inspections,\u003c/strong\u003e\u0026nbsp;developing responses to FDA investigational observations (FDA-483 forms), and warning letters.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e\u0026nbsp;under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong\u003einternal investigations of pharmaceutical medical device manufacturers\u003c/strong\u003e\u0026nbsp;into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFDA regulatory due diligence reviews\u003c/strong\u003e\u0026nbsp;of target medical device, pharmaceutical manufacturers, and compounding pharmacies.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eradiation-emitting product requirements\u003c/strong\u003e\u0026nbsp;under the FDCA.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003elabeling and promotion requirements\u003c/strong\u003e\u0026nbsp;for FDA-regulated products.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eUnited States v. Franck\u0026rsquo;s Lab\u003c/em\u003e, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFranck\u0026rsquo;s Lab\u003c/strong\u003e\u0026nbsp;in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA\u0026rsquo;s statute. Also served as the lead associate for Franck\u0026rsquo;s Lab in other FDA regulatory and state board of pharmacy matters.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eHill Dermaceuticals, Inc. v.\u003c/em\u003e\u0026nbsp;FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003einnovator drug manufacturer\u003c/strong\u003e\u0026nbsp;in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer\u0026rsquo;s brand name products.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":174}]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":2,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":3,"source":"capabilities"},{"id":114,"guid":"114.capabilities","index":4,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":5,"source":"capabilities"},{"id":1199,"guid":"1199.smart_tags","index":6,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":7,"source":"smartTags"},{"id":1223,"guid":"1223.smart_tags","index":8,"source":"smartTags"},{"id":128,"guid":"128.capabilities","index":9,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":10,"source":"capabilities"},{"id":1206,"guid":"1206.smart_tags","index":11,"source":"smartTags"}],"is_active":true,"last_name":"Klingler","nick_name":"Amanda","clerkships":[],"first_name":"Amanda","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"J.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAmanda Klingler is a partner in the firm\u0026rsquo;s Washington, D.C. and Chicago offices with extensive experience advising life science clients.\u0026nbsp; As a partner in the firm's FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAmanda counsels clients on pre- and post-marketing regulatory activities and strategies, including obtaining FDA approval and clearance for medical products.\u0026nbsp; Amanda also regularly advises clients on product labeling, adverse event reporting, product safety issues, recalls/field corrections, import detention, and advertising and promotion issues.\u0026nbsp; She counsels clients on quality system and manufacturing practices for drugs and medical devices and factory inspections, including conducting mock inspections and working closely with and providing advice to clients during the inspection, and provide guidance in responding to FDA investigational observations (FDA-483 forms), and warning letters.\u0026nbsp;\u0026nbsp;Amanda, as a co-leader of the firm\u0026rsquo;s AI/ML Tactical Operations team, also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAmanda advises clients during internal and government investigations.\u0026nbsp; She also assists in the negotiation and management of several consent decrees of injunction for pharmaceutical, medical device, food companies and compounding pharmacies.\u003c/p\u003e\n\u003cp\u003eAmanda works closely with the firm's product liability team and is experienced in handling FDA issues in product liability litigation, including the development of supporting evidence, writing briefs, and preparing expert witnesses to testify.\u003c/p\u003e\n\u003cp\u003eAmanda also has significant experience and expertise in FDA's regulation of tobacco products.\u003c/p\u003e","matters":["\u003cp\u003e\u003cem\u003ePhillips Morris USA v. FDA,\u0026nbsp;\u003c/em\u003e202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eproduct liability litigation\u003c/strong\u003einvolving GlaxoSmithKline\u0026rsquo;s antidepressant Paxil\u0026reg;, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003ein limine\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003eDaubert\u003c/em\u003echallenges.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team representing the\u0026nbsp;\u003cstrong\u003emanufacturer of FDA-cleared surgical gowns\u0026nbsp;\u003c/strong\u003ein nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a\u0026nbsp;\u003cem\u003equi tam\u0026nbsp;\u003c/em\u003esuit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ecompanies in preparing for FDA inspections,\u003c/strong\u003e\u0026nbsp;developing responses to FDA investigational observations (FDA-483 forms), and warning letters.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e\u0026nbsp;under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong\u003einternal investigations of pharmaceutical medical device manufacturers\u003c/strong\u003e\u0026nbsp;into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFDA regulatory due diligence reviews\u003c/strong\u003e\u0026nbsp;of target medical device, pharmaceutical manufacturers, and compounding pharmacies.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eradiation-emitting product requirements\u003c/strong\u003e\u0026nbsp;under the FDCA.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003elabeling and promotion requirements\u003c/strong\u003e\u0026nbsp;for FDA-regulated products.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eUnited States v. Franck\u0026rsquo;s Lab\u003c/em\u003e, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFranck\u0026rsquo;s Lab\u003c/strong\u003e\u0026nbsp;in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA\u0026rsquo;s statute. Also served as the lead associate for Franck\u0026rsquo;s Lab in other FDA regulatory and state board of pharmacy matters.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eHill Dermaceuticals, Inc. v.\u003c/em\u003e\u0026nbsp;FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003einnovator drug manufacturer\u003c/strong\u003e\u0026nbsp;in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer\u0026rsquo;s brand name products.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4350}]},"capability_group_id":2},"created_at":"2025-10-08T19:11:18.000Z","updated_at":"2025-10-08T19:11:18.000Z","searchable_text":"Klingler{{ FIELD }}Phillips Morris USA v. FDA, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.{{ FIELD }}Member of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in product liability litigationinvolving GlaxoSmithKline’s antidepressant Paxil®, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions in limine and Daubertchallenges.{{ FIELD }}Member of a King \u0026amp; Spalding team representing the manufacturer of FDA-cleared surgical gowns in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a qui tam suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony.{{ FIELD }}Assisted companies in preparing for FDA inspections, developing responses to FDA investigational observations (FDA-483 forms), and warning letters.{{ FIELD }}Assisted pharmaceutical and medical device companies under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA.{{ FIELD }}Conducted internal investigations of pharmaceutical medical device manufacturers into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure.{{ FIELD }}Conducted FDA regulatory due diligence reviews of target medical device, pharmaceutical manufacturers, and compounding pharmacies.{{ FIELD }}Counseled companies on radiation-emitting product requirements under the FDCA.{{ FIELD }}Counseled companies on labeling and promotion requirements for FDA-regulated products.{{ FIELD }}United States v. Franck’s Lab, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for Franck’s Lab in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA’s statute. Also served as the lead associate for Franck’s Lab in other FDA regulatory and state board of pharmacy matters.{{ FIELD }}Hill Dermaceuticals, Inc. v. FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing innovator drug manufacturer in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer’s brand name products.{{ FIELD }}Amanda Klingler is a partner in the firm’s Washington, D.C. and Chicago offices with extensive experience advising life science clients.  As a partner in the firm's FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling. \nAmanda counsels clients on pre- and post-marketing regulatory activities and strategies, including obtaining FDA approval and clearance for medical products.  Amanda also regularly advises clients on product labeling, adverse event reporting, product safety issues, recalls/field corrections, import detention, and advertising and promotion issues.  She counsels clients on quality system and manufacturing practices for drugs and medical devices and factory inspections, including conducting mock inspections and working closely with and providing advice to clients during the inspection, and provide guidance in responding to FDA investigational observations (FDA-483 forms), and warning letters.  Amanda, as a co-leader of the firm’s AI/ML Tactical Operations team, also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products. \nAmanda advises clients during internal and government investigations.  She also assists in the negotiation and management of several consent decrees of injunction for pharmaceutical, medical device, food companies and compounding pharmacies.\nAmanda works closely with the firm's product liability team and is experienced in handling FDA issues in product liability litigation, including the development of supporting evidence, writing briefs, and preparing expert witnesses to testify.\nAmanda also has significant experience and expertise in FDA's regulation of tobacco products. Amanda J Klingler Partner University of Richmond University of Richmond School of Law Saint Louis University Saint Louis University School of Law Loyola University Chicago Loyola University Chicago School of Law District of Columbia Illinois Phillips Morris USA v. FDA, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products. Member of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in product liability litigationinvolving GlaxoSmithKline’s antidepressant Paxil®, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions in limine and Daubertchallenges. Member of a King \u0026amp; Spalding team representing the manufacturer of FDA-cleared surgical gowns in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a qui tam suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony. Assisted companies in preparing for FDA inspections, developing responses to FDA investigational observations (FDA-483 forms), and warning letters. Assisted pharmaceutical and medical device companies under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA. Conducted internal investigations of pharmaceutical medical device manufacturers into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure. Conducted FDA regulatory due diligence reviews of target medical device, pharmaceutical manufacturers, and compounding pharmacies. Counseled companies on radiation-emitting product requirements under the FDCA. Counseled companies on labeling and promotion requirements for FDA-regulated products. United States v. Franck’s Lab, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for Franck’s Lab in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA’s statute. Also served as the lead associate for Franck’s Lab in other FDA regulatory and state board of pharmacy matters. Hill Dermaceuticals, Inc. v. FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing innovator drug manufacturer in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer’s brand name products.","searchable_name":"Amanda J. Klingler","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":441625,"version":1,"owner_type":"Person","owner_id":673,"payload":{"bio":"\u003cp\u003eAlec Koch is a co-leader of our Securities Enforcement and Regulation practice and a former Assistant Director with the Securities and Exchange Commission's Division of Enforcement.\u0026nbsp; He represents public companies, financial institutions, boards of directors, and individuals in securities enforcement and anti-corruption investigations before the SEC, DOJ, PCAOB, and other regulatory authorities.\u0026nbsp; Nationally ranked by \u003cem\u003eChambers USA\u003c/em\u003e, Alec is described as having \"broad market approval for his enforcement-side practice.\"\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;Alec also regularly conducts internal investigations on behalf of companies and board committees, often involving multiple jurisdictions,\u0026nbsp;and advises clients on regulatory compliance and corporate governance issues.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAt the SEC, Alec supervised investigations of all types, including matters involving public company accounting and disclosure; The Foreign Corrupt Practices Act; insider trading; regulated entities such as broker-dealers,\u0026nbsp;investment advisers,\u0026nbsp;and credit rating agencies; market manipulation; and securities offerings.\u0026nbsp; He served in multiple leadership roles, including as a member of the Division of Enforcement\u0026rsquo;s Broker-Dealer Task Force, as the co-chair of the Division's\u0026nbsp;Priorities and Resources Subcommittee, and as a liaison\u0026nbsp;between the Division of Enforcement and the SEC\u0026rsquo;s Office of Credit Ratings.\u003c/p\u003e\n\u003cp\u003eAlec\u0026nbsp;serves\u0026nbsp;on the board of directors of Legal Aid D.C.\u0026nbsp;and the Ethics Research Center, a\u0026nbsp;non-profit organization that works to assist public companies and other institutions with building strong ethics and compliance\u0026nbsp;programs.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePrior to working at the\u0026nbsp;SEC, Alec was an associate at King \u0026amp; Spalding from 1997-2002. He rejoined the firm in 2016.\u003c/p\u003e","slug":"alec-koch","email":"akoch@kslaw.com","phone":"+1 202 740 4863","matters":["\u003cp\u003eRepresenting a\u0026nbsp;\u003cstrong\u003eprovider and operator of compression infrastructure used in the production and transfer of oil and natural gas\u003c/strong\u003e\u0026nbsp;in an investigation related to payments potentially made to Mexican cartels designated as foreign terrorist organizations (FTOs).\u003c/p\u003e","\u003cp\u003eRepresenting the\u0026nbsp;\u003cstrong\u003eaudit committee of a global non-clinical global drug development company\u003c/strong\u003e\u0026nbsp;in an internal investigation related to potential FCPA and disclosure violations.\u003c/p\u003e","\u003cp\u003eRepresenting a\u0026nbsp;\u003cstrong\u003eBig Four accounting firm\u003c/strong\u003e\u0026nbsp;in investigations and securities litigation resulting from the sudden closure of several banks for which the firm acted as external auditor.\u003c/p\u003e","\u003cp\u003eRepresenting the\u0026nbsp;\u003cstrong\u003eCISO of a software development company\u003c/strong\u003e\u0026nbsp;in a first-of-its-kind SEC enforcement action relating to the company's disclosures concerning cybersecurity.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eprovider of life and health insurance\u003c/strong\u003e\u0026nbsp;in SEC and DOJ investigations related to allegations made by short sellers regarding the company's financial performance and independent agents. The investigations were closed without enforcement action.\u003c/p\u003e","\u003cp\u003eServed as the Independent Compliance Consultant for a\u0026nbsp;\u003cstrong\u003eregistered clearing agency\u003c/strong\u003e\u0026nbsp;in connection with its SEC settlement relating to liquidity arrangements.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emultinational healthcare company\u003c/strong\u003e\u0026nbsp;in connection with its continuing self-reporting obligations under an FCPA settlement with the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eglobal manufacturing company\u003c/strong\u003e\u0026nbsp;in an SEC investigation of potential FCPA violations in South America that was closed without enforcement action.\u003c/p\u003e","\u003cp\u003eRepresenting the Audit Committee of\u0026nbsp;\u003cstrong\u003ea space infrastructure development company\u003c/strong\u003e\u0026nbsp;in an independent investigation of accounting and employment allegations raised by a former employee.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eglobal manufacturing company\u003c/strong\u003e\u0026nbsp;in an SEC investigation concerning air emissions-related issues that was closed without enforcement action.\u003c/p\u003e","\u003cp\u003eRepresented an\u0026nbsp;\u003cstrong\u003einternational chemical company\u0026nbsp;\u003c/strong\u003ein a negotiated resolution of anti-corruption investigations conducted by U.S. and Dutch authorities.\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eaudit committee of a public biopharmaceutical company\u003c/strong\u003e\u0026nbsp;in an internal investigation and related government investigations into allegations of accounting fraud and whistleblower retaliation.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003epublic company provider of services to the healthcare industry\u003c/strong\u003e\u0026nbsp;in an SEC investigation of earnings-related disclosures that was resolved on favorable terms.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003epublic pharmaceutical company\u003c/strong\u003e\u0026nbsp;in an SEC investigation of potential selective disclosures and Reg FD violations that was resolved on favorable terms.\u003c/p\u003e","\u003cp\u003eRepresented the\u003cstrong\u003e\u0026nbsp;independent directors of a commercial flooring company\u003c/strong\u003e\u0026nbsp;in an SEC investigation of earnings-related disclosures.\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eindependent directors of a public company\u003c/strong\u003e\u0026nbsp;in connection with an SEC investigation of earnings-related disclosures.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ethe CEO of a healthcare logistics company\u003c/strong\u003e\u0026nbsp;in SEC and DOJ investigations of the company's disclosures concerning PPE transactions.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003epublic electrical utility\u003c/strong\u003e\u0026nbsp;in an SEC investigation of the utility\u0026rsquo;s historical bond offerings.\u003c/p\u003e","\u003cp\u003eRepresented\u003cstrong\u003e\u0026nbsp;one of the world\u0026rsquo;s largest banks\u003c/strong\u003e\u0026nbsp;in a DOJ investigation concerning the origination and sale of residential mortgage-backed securities during the years leading up to the financial crisis.\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eaudit committee of a public media analytics company\u003c/strong\u003e\u0026nbsp;in an internal investigation and related government investigations into more than 20 separate allegations of accounting fraud and whistleblower retaliation.\u003c/p\u003e","\u003cp\u003eDefended\u003cstrong\u003e\u0026nbsp;a major U.S. law firm and several of its partners and employees\u003c/strong\u003e\u0026nbsp;in an SEC investigation concerning the activities of the firm\u0026rsquo;s former client, an asset manager. The matter was closed without enforcement action.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":175}]},"expertise":[{"id":20,"guid":"20.capabilities","index":0,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":1,"source":"capabilities"},{"id":780,"guid":"780.smart_tags","index":2,"source":"smartTags"},{"id":1188,"guid":"1188.smart_tags","index":3,"source":"smartTags"},{"id":27,"guid":"27.capabilities","index":4,"source":"capabilities"},{"id":126,"guid":"126.capabilities","index":5,"source":"capabilities"},{"id":699,"guid":"699.smart_tags","index":6,"source":"smartTags"},{"id":18,"guid":"18.capabilities","index":7,"source":"capabilities"},{"id":111,"guid":"111.capabilities","index":8,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":9,"source":"capabilities"},{"id":19,"guid":"19.capabilities","index":10,"source":"capabilities"},{"id":127,"guid":"127.capabilities","index":11,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":12,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":13,"source":"capabilities"},{"id":1184,"guid":"1184.smart_tags","index":14,"source":"smartTags"},{"id":1241,"guid":"1241.smart_tags","index":15,"source":"smartTags"},{"id":1261,"guid":"1261.smart_tags","index":16,"source":"smartTags"},{"id":1434,"guid":"1434.smart_tags","index":17,"source":"smartTags"}],"is_active":true,"last_name":"Koch","nick_name":"Alec","clerkships":[],"first_name":"Alec","title_rank":9999,"updated_by":202,"law_schools":[{"id":755,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":"1","graduation_date":"1997-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Top Ranked Lawyer, Securities: Regulation: Enforcement ","detail":"Chambers USA, Nationwide (2019-PRESENT)"},{"title":"Recognized for \"broad market approval for his enforcement-side practice\" and described as \"an extraordinary lawyer.\"","detail":"Chambers USA, Securities Regulation: Enforcement - USA - Nationwide"}],"linked_in_url":"https://www.linkedin.com/in/alec-koch-75a5412b/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAlec Koch is a co-leader of our Securities Enforcement and Regulation practice and a former Assistant Director with the Securities and Exchange Commission's Division of Enforcement.\u0026nbsp; He represents public companies, financial institutions, boards of directors, and individuals in securities enforcement and anti-corruption investigations before the SEC, DOJ, PCAOB, and other regulatory authorities.\u0026nbsp; Nationally ranked by \u003cem\u003eChambers USA\u003c/em\u003e, Alec is described as having \"broad market approval for his enforcement-side practice.\"\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;Alec also regularly conducts internal investigations on behalf of companies and board committees, often involving multiple jurisdictions,\u0026nbsp;and advises clients on regulatory compliance and corporate governance issues.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAt the SEC, Alec supervised investigations of all types, including matters involving public company accounting and disclosure; The Foreign Corrupt Practices Act; insider trading; regulated entities such as broker-dealers,\u0026nbsp;investment advisers,\u0026nbsp;and credit rating agencies; market manipulation; and securities offerings.\u0026nbsp; He served in multiple leadership roles, including as a member of the Division of Enforcement\u0026rsquo;s Broker-Dealer Task Force, as the co-chair of the Division's\u0026nbsp;Priorities and Resources Subcommittee, and as a liaison\u0026nbsp;between the Division of Enforcement and the SEC\u0026rsquo;s Office of Credit Ratings.\u003c/p\u003e\n\u003cp\u003eAlec\u0026nbsp;serves\u0026nbsp;on the board of directors of Legal Aid D.C.\u0026nbsp;and the Ethics Research Center, a\u0026nbsp;non-profit organization that works to assist public companies and other institutions with building strong ethics and compliance\u0026nbsp;programs.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePrior to working at the\u0026nbsp;SEC, Alec was an associate at King \u0026amp; Spalding from 1997-2002. He rejoined the firm in 2016.\u003c/p\u003e","matters":["\u003cp\u003eRepresenting a\u0026nbsp;\u003cstrong\u003eprovider and operator of compression infrastructure used in the production and transfer of oil and natural gas\u003c/strong\u003e\u0026nbsp;in an investigation related to payments potentially made to Mexican cartels designated as foreign terrorist organizations (FTOs).\u003c/p\u003e","\u003cp\u003eRepresenting the\u0026nbsp;\u003cstrong\u003eaudit committee of a global non-clinical global drug development company\u003c/strong\u003e\u0026nbsp;in an internal investigation related to potential FCPA and disclosure violations.\u003c/p\u003e","\u003cp\u003eRepresenting a\u0026nbsp;\u003cstrong\u003eBig Four accounting firm\u003c/strong\u003e\u0026nbsp;in investigations and securities litigation resulting from the sudden closure of several banks for which the firm acted as external auditor.\u003c/p\u003e","\u003cp\u003eRepresenting the\u0026nbsp;\u003cstrong\u003eCISO of a software development company\u003c/strong\u003e\u0026nbsp;in a first-of-its-kind SEC enforcement action relating to the company's disclosures concerning cybersecurity.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eprovider of life and health insurance\u003c/strong\u003e\u0026nbsp;in SEC and DOJ investigations related to allegations made by short sellers regarding the company's financial performance and independent agents. The investigations were closed without enforcement action.\u003c/p\u003e","\u003cp\u003eServed as the Independent Compliance Consultant for a\u0026nbsp;\u003cstrong\u003eregistered clearing agency\u003c/strong\u003e\u0026nbsp;in connection with its SEC settlement relating to liquidity arrangements.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emultinational healthcare company\u003c/strong\u003e\u0026nbsp;in connection with its continuing self-reporting obligations under an FCPA settlement with the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eglobal manufacturing company\u003c/strong\u003e\u0026nbsp;in an SEC investigation of potential FCPA violations in South America that was closed without enforcement action.\u003c/p\u003e","\u003cp\u003eRepresenting the Audit Committee of\u0026nbsp;\u003cstrong\u003ea space infrastructure development company\u003c/strong\u003e\u0026nbsp;in an independent investigation of accounting and employment allegations raised by a former employee.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eglobal manufacturing company\u003c/strong\u003e\u0026nbsp;in an SEC investigation concerning air emissions-related issues that was closed without enforcement action.\u003c/p\u003e","\u003cp\u003eRepresented an\u0026nbsp;\u003cstrong\u003einternational chemical company\u0026nbsp;\u003c/strong\u003ein a negotiated resolution of anti-corruption investigations conducted by U.S. and Dutch authorities.\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eaudit committee of a public biopharmaceutical company\u003c/strong\u003e\u0026nbsp;in an internal investigation and related government investigations into allegations of accounting fraud and whistleblower retaliation.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003epublic company provider of services to the healthcare industry\u003c/strong\u003e\u0026nbsp;in an SEC investigation of earnings-related disclosures that was resolved on favorable terms.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003epublic pharmaceutical company\u003c/strong\u003e\u0026nbsp;in an SEC investigation of potential selective disclosures and Reg FD violations that was resolved on favorable terms.\u003c/p\u003e","\u003cp\u003eRepresented the\u003cstrong\u003e\u0026nbsp;independent directors of a commercial flooring company\u003c/strong\u003e\u0026nbsp;in an SEC investigation of earnings-related disclosures.\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eindependent directors of a public company\u003c/strong\u003e\u0026nbsp;in connection with an SEC investigation of earnings-related disclosures.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ethe CEO of a healthcare logistics company\u003c/strong\u003e\u0026nbsp;in SEC and DOJ investigations of the company's disclosures concerning PPE transactions.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003epublic electrical utility\u003c/strong\u003e\u0026nbsp;in an SEC investigation of the utility\u0026rsquo;s historical bond offerings.\u003c/p\u003e","\u003cp\u003eRepresented\u003cstrong\u003e\u0026nbsp;one of the world\u0026rsquo;s largest banks\u003c/strong\u003e\u0026nbsp;in a DOJ investigation concerning the origination and sale of residential mortgage-backed securities during the years leading up to the financial crisis.\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eaudit committee of a public media analytics company\u003c/strong\u003e\u0026nbsp;in an internal investigation and related government investigations into more than 20 separate allegations of accounting fraud and whistleblower retaliation.\u003c/p\u003e","\u003cp\u003eDefended\u003cstrong\u003e\u0026nbsp;a major U.S. law firm and several of its partners and employees\u003c/strong\u003e\u0026nbsp;in an SEC investigation concerning the activities of the firm\u0026rsquo;s former client, an asset manager. The matter was closed without enforcement action.\u003c/p\u003e"],"recognitions":[{"title":"Top Ranked Lawyer, Securities: Regulation: Enforcement ","detail":"Chambers USA, Nationwide (2019-PRESENT)"},{"title":"Recognized for \"broad market approval for his enforcement-side practice\" and described as \"an extraordinary lawyer.\"","detail":"Chambers USA, Securities Regulation: Enforcement - USA - Nationwide"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9976}]},"capability_group_id":2},"created_at":"2025-10-21T18:47:33.000Z","updated_at":"2025-10-21T18:47:33.000Z","searchable_text":"Koch{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, Securities: Regulation: Enforcement \", :detail=\u0026gt;\"Chambers USA, Nationwide (2019-PRESENT)\"}{{ FIELD }}{:title=\u0026gt;\"Recognized for \\\"broad market approval for his enforcement-side practice\\\" and described as \\\"an extraordinary lawyer.\\\"\", :detail=\u0026gt;\"Chambers USA, Securities Regulation: Enforcement - USA - Nationwide\"}{{ FIELD }}Representing a provider and operator of compression infrastructure used in the production and transfer of oil and natural gas in an investigation related to payments potentially made to Mexican cartels designated as foreign terrorist organizations (FTOs).{{ FIELD }}Representing the audit committee of a global non-clinical global drug development company in an internal investigation related to potential FCPA and disclosure violations.{{ FIELD }}Representing a Big Four accounting firm in investigations and securities litigation resulting from the sudden closure of several banks for which the firm acted as external auditor.{{ FIELD }}Representing the CISO of a software development company in a first-of-its-kind SEC enforcement action relating to the company's disclosures concerning cybersecurity.{{ FIELD }}Represented a provider of life and health insurance in SEC and DOJ investigations related to allegations made by short sellers regarding the company's financial performance and independent agents. The investigations were closed without enforcement action.{{ FIELD }}Served as the Independent Compliance Consultant for a registered clearing agency in connection with its SEC settlement relating to liquidity arrangements.{{ FIELD }}Represented a multinational healthcare company in connection with its continuing self-reporting obligations under an FCPA settlement with the DOJ and SEC.{{ FIELD }}Represented a global manufacturing company in an SEC investigation of potential FCPA violations in South America that was closed without enforcement action.{{ FIELD }}Representing the Audit Committee of a space infrastructure development company in an independent investigation of accounting and employment allegations raised by a former employee.{{ FIELD }}Represented a global manufacturing company in an SEC investigation concerning air emissions-related issues that was closed without enforcement action.{{ FIELD }}Represented an international chemical company in a negotiated resolution of anti-corruption investigations conducted by U.S. and Dutch authorities.{{ FIELD }}Represented the audit committee of a public biopharmaceutical company in an internal investigation and related government investigations into allegations of accounting fraud and whistleblower retaliation.{{ FIELD }}Represented a public company provider of services to the healthcare industry in an SEC investigation of earnings-related disclosures that was resolved on favorable terms.{{ FIELD }}Represented a public pharmaceutical company in an SEC investigation of potential selective disclosures and Reg FD violations that was resolved on favorable terms.{{ FIELD }}Represented the independent directors of a commercial flooring company in an SEC investigation of earnings-related disclosures.{{ FIELD }}Represented the independent directors of a public company in connection with an SEC investigation of earnings-related disclosures.{{ FIELD }}Represented the CEO of a healthcare logistics company in SEC and DOJ investigations of the company's disclosures concerning PPE transactions.{{ FIELD }}Represented a public electrical utility in an SEC investigation of the utility’s historical bond offerings.{{ FIELD }}Represented one of the world’s largest banks in a DOJ investigation concerning the origination and sale of residential mortgage-backed securities during the years leading up to the financial crisis.{{ FIELD }}Represented the audit committee of a public media analytics company in an internal investigation and related government investigations into more than 20 separate allegations of accounting fraud and whistleblower retaliation.{{ FIELD }}Defended a major U.S. law firm and several of its partners and employees in an SEC investigation concerning the activities of the firm’s former client, an asset manager. The matter was closed without enforcement action.{{ FIELD }}Alec Koch is a co-leader of our Securities Enforcement and Regulation practice and a former Assistant Director with the Securities and Exchange Commission's Division of Enforcement.  He represents public companies, financial institutions, boards of directors, and individuals in securities enforcement and anti-corruption investigations before the SEC, DOJ, PCAOB, and other regulatory authorities.  Nationally ranked by Chambers USA, Alec is described as having \"broad market approval for his enforcement-side practice.\"\n Alec also regularly conducts internal investigations on behalf of companies and board committees, often involving multiple jurisdictions, and advises clients on regulatory compliance and corporate governance issues. \nAt the SEC, Alec supervised investigations of all types, including matters involving public company accounting and disclosure; The Foreign Corrupt Practices Act; insider trading; regulated entities such as broker-dealers, investment advisers, and credit rating agencies; market manipulation; and securities offerings.  He served in multiple leadership roles, including as a member of the Division of Enforcement’s Broker-Dealer Task Force, as the co-chair of the Division's Priorities and Resources Subcommittee, and as a liaison between the Division of Enforcement and the SEC’s Office of Credit Ratings.\nAlec serves on the board of directors of Legal Aid D.C. and the Ethics Research Center, a non-profit organization that works to assist public companies and other institutions with building strong ethics and compliance programs.  \nPrior to working at the SEC, Alec was an associate at King \u0026amp; Spalding from 1997-2002. He rejoined the firm in 2016. M Alexander Koch Partner Top Ranked Lawyer, Securities: Regulation: Enforcement  Chambers USA, Nationwide (2019-PRESENT) Recognized for \"broad market approval for his enforcement-side practice\" and described as \"an extraordinary lawyer.\" Chambers USA, Securities Regulation: Enforcement - USA - Nationwide University of Virginia University of Virginia School of Law Georgetown University Georgetown University Law Center District of Columbia Representing a provider and operator of compression infrastructure used in the production and transfer of oil and natural gas in an investigation related to payments potentially made to Mexican cartels designated as foreign terrorist organizations (FTOs). Representing the audit committee of a global non-clinical global drug development company in an internal investigation related to potential FCPA and disclosure violations. Representing a Big Four accounting firm in investigations and securities litigation resulting from the sudden closure of several banks for which the firm acted as external auditor. Representing the CISO of a software development company in a first-of-its-kind SEC enforcement action relating to the company's disclosures concerning cybersecurity. Represented a provider of life and health insurance in SEC and DOJ investigations related to allegations made by short sellers regarding the company's financial performance and independent agents. The investigations were closed without enforcement action. Served as the Independent Compliance Consultant for a registered clearing agency in connection with its SEC settlement relating to liquidity arrangements. Represented a multinational healthcare company in connection with its continuing self-reporting obligations under an FCPA settlement with the DOJ and SEC. Represented a global manufacturing company in an SEC investigation of potential FCPA violations in South America that was closed without enforcement action. Representing the Audit Committee of a space infrastructure development company in an independent investigation of accounting and employment allegations raised by a former employee. Represented a global manufacturing company in an SEC investigation concerning air emissions-related issues that was closed without enforcement action. Represented an international chemical company in a negotiated resolution of anti-corruption investigations conducted by U.S. and Dutch authorities. Represented the audit committee of a public biopharmaceutical company in an internal investigation and related government investigations into allegations of accounting fraud and whistleblower retaliation. Represented a public company provider of services to the healthcare industry in an SEC investigation of earnings-related disclosures that was resolved on favorable terms. Represented a public pharmaceutical company in an SEC investigation of potential selective disclosures and Reg FD violations that was resolved on favorable terms. Represented the independent directors of a commercial flooring company in an SEC investigation of earnings-related disclosures. Represented the independent directors of a public company in connection with an SEC investigation of earnings-related disclosures. Represented the CEO of a healthcare logistics company in SEC and DOJ investigations of the company's disclosures concerning PPE transactions. Represented a public electrical utility in an SEC investigation of the utility’s historical bond offerings. Represented one of the world’s largest banks in a DOJ investigation concerning the origination and sale of residential mortgage-backed securities during the years leading up to the financial crisis. Represented the audit committee of a public media analytics company in an internal investigation and related government investigations into more than 20 separate allegations of accounting fraud and whistleblower retaliation. Defended a major U.S. law firm and several of its partners and employees in an SEC investigation concerning the activities of the firm’s former client, an asset manager. The matter was closed without enforcement action.","searchable_name":"Alec Koch","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":436458,"version":1,"owner_type":"Person","owner_id":4210,"payload":{"bio":"\u003cp\u003eSteven Kupka is a partner in King \u0026amp; Spalding\u0026rsquo;s Special Matters \u0026amp; Government Investigations practice group.\u0026nbsp;\u0026nbsp;An expert on the complexities of public policy and regulatory law at the federal, state, and local government levels, Mr. Kupka focuses his practice on international trade, foreign regulatory issues and foreign asset recovery efforts with a particular emphasis on\u0026nbsp;Latin America.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eU.S. and foreign governmental entities turn to Mr. Kupka for specialized advice on myriad topics including energy infrastructure projects, regulatory compliance and enforcement issues. He also advises corporations and State agencies on their advocacy efforts before Congress regarding legislative and regulatory issues and on various interagency rulings issued by the Office of Management and Budget.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Mr. Kupka was Managing Partner for the Washington, DC office of a national law firm where he also led the firm\u0026rsquo;s Government Contracts, Public Policy, Regulatory \u0026amp; Government Affairs groups.\u003c/p\u003e\n\u003cp\u003eMr. Kupka\u0026rsquo;s extensive government and public policy credentials include work for The White House Office of Management and Budget, the Central Intelligence Agency, the Federal Trade Commission and the U.S. House of Representatives. He also served as Chief of Staff to the Mayor of Omaha and had leadership positions in several U.S. presidential campaigns in Nebraska and the U.S. Territories. He is a member of the Republican Governors Association Executive Roundtable and also served\u0026nbsp;on the Board of Directors of the Boulder Crest\u0026nbsp;Foundation for\u0026nbsp;Wounded EOD Warriors.\u003c/p\u003e","slug":"steven-kupka","email":"skupka@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented many U.S. clients before foreign executive branch agencies in the Americas.\u003c/p\u003e","\u003cp\u003eRepresents clients in the federal regulatory healthcare space at FDA, CMS and HHS.\u003c/p\u003e","\u003cp\u003eRepresented client interests before the House and Senate Committees and Subcommittees.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":35,"guid":"35.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":25,"guid":"25.capabilities","index":2,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":3,"source":"capabilities"}],"is_active":true,"last_name":"Kupka","nick_name":"Steve","clerkships":[],"first_name":"Steven","title_rank":9999,"updated_by":202,"law_schools":[{"id":518,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"1989-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"M.","name_suffix":"","recognitions":[{"title":"Best YPO Event for \"Inside Puerto Rico\"","detail":"LATIN AMERICA REGIONAL YPO COMMITTEE, 2019"},{"title":"International Award for Best Education Event for the “Inside Washington Seminar”","detail":"Young Presidents’ Organization, 2013"},{"title":"International Award for Best Education Event ","detail":"Young Presidents’ Organization, 2015 and 2016"},{"title":"Named in \"Power 100: Washington's Most Influential\" ","detail":"Washington Life Magazine"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eSteven Kupka is a partner in King \u0026amp; Spalding\u0026rsquo;s Special Matters \u0026amp; Government Investigations practice group.\u0026nbsp;\u0026nbsp;An expert on the complexities of public policy and regulatory law at the federal, state, and local government levels, Mr. Kupka focuses his practice on international trade, foreign regulatory issues and foreign asset recovery efforts with a particular emphasis on\u0026nbsp;Latin America.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eU.S. and foreign governmental entities turn to Mr. Kupka for specialized advice on myriad topics including energy infrastructure projects, regulatory compliance and enforcement issues. He also advises corporations and State agencies on their advocacy efforts before Congress regarding legislative and regulatory issues and on various interagency rulings issued by the Office of Management and Budget.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Mr. Kupka was Managing Partner for the Washington, DC office of a national law firm where he also led the firm\u0026rsquo;s Government Contracts, Public Policy, Regulatory \u0026amp; Government Affairs groups.\u003c/p\u003e\n\u003cp\u003eMr. Kupka\u0026rsquo;s extensive government and public policy credentials include work for The White House Office of Management and Budget, the Central Intelligence Agency, the Federal Trade Commission and the U.S. House of Representatives. He also served as Chief of Staff to the Mayor of Omaha and had leadership positions in several U.S. presidential campaigns in Nebraska and the U.S. Territories. He is a member of the Republican Governors Association Executive Roundtable and also served\u0026nbsp;on the Board of Directors of the Boulder Crest\u0026nbsp;Foundation for\u0026nbsp;Wounded EOD Warriors.\u003c/p\u003e","matters":["\u003cp\u003eRepresented many U.S. clients before foreign executive branch agencies in the Americas.\u003c/p\u003e","\u003cp\u003eRepresents clients in the federal regulatory healthcare space at FDA, CMS and HHS.\u003c/p\u003e","\u003cp\u003eRepresented client interests before the House and Senate Committees and Subcommittees.\u003c/p\u003e"],"recognitions":[{"title":"Best YPO Event for \"Inside Puerto Rico\"","detail":"LATIN AMERICA REGIONAL YPO COMMITTEE, 2019"},{"title":"International Award for Best Education Event for the “Inside Washington Seminar”","detail":"Young Presidents’ Organization, 2013"},{"title":"International Award for Best Education Event ","detail":"Young Presidents’ Organization, 2015 and 2016"},{"title":"Named in \"Power 100: Washington's Most Influential\" ","detail":"Washington Life Magazine"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":981}]},"capability_group_id":1},"created_at":"2025-09-02T04:55:02.000Z","updated_at":"2025-09-02T04:55:02.000Z","searchable_text":"Kupka{{ FIELD }}{:title=\u0026gt;\"Best YPO Event for \\\"Inside Puerto Rico\\\"\", :detail=\u0026gt;\"LATIN AMERICA REGIONAL YPO COMMITTEE, 2019\"}{{ FIELD }}{:title=\u0026gt;\"International Award for Best Education Event for the “Inside Washington Seminar”\", :detail=\u0026gt;\"Young Presidents’ Organization, 2013\"}{{ FIELD }}{:title=\u0026gt;\"International Award for Best Education Event \", :detail=\u0026gt;\"Young Presidents’ Organization, 2015 and 2016\"}{{ FIELD }}{:title=\u0026gt;\"Named in \\\"Power 100: Washington's Most Influential\\\" \", :detail=\u0026gt;\"Washington Life Magazine\"}{{ FIELD }}Represented many U.S. clients before foreign executive branch agencies in the Americas.{{ FIELD }}Represents clients in the federal regulatory healthcare space at FDA, CMS and HHS.{{ FIELD }}Represented client interests before the House and Senate Committees and Subcommittees.{{ FIELD }}Steven Kupka is a partner in King \u0026amp; Spalding’s Special Matters \u0026amp; Government Investigations practice group.  An expert on the complexities of public policy and regulatory law at the federal, state, and local government levels, Mr. Kupka focuses his practice on international trade, foreign regulatory issues and foreign asset recovery efforts with a particular emphasis on Latin America. \nU.S. and foreign governmental entities turn to Mr. Kupka for specialized advice on myriad topics including energy infrastructure projects, regulatory compliance and enforcement issues. He also advises corporations and State agencies on their advocacy efforts before Congress regarding legislative and regulatory issues and on various interagency rulings issued by the Office of Management and Budget.\nPrior to joining King \u0026amp; Spalding, Mr. Kupka was Managing Partner for the Washington, DC office of a national law firm where he also led the firm’s Government Contracts, Public Policy, Regulatory \u0026amp; Government Affairs groups.\nMr. Kupka’s extensive government and public policy credentials include work for The White House Office of Management and Budget, the Central Intelligence Agency, the Federal Trade Commission and the U.S. House of Representatives. He also served as Chief of Staff to the Mayor of Omaha and had leadership positions in several U.S. presidential campaigns in Nebraska and the U.S. Territories. He is a member of the Republican Governors Association Executive Roundtable and also served on the Board of Directors of the Boulder Crest Foundation for Wounded EOD Warriors. Partner Best YPO Event for \"Inside Puerto Rico\" LATIN AMERICA REGIONAL YPO COMMITTEE, 2019 International Award for Best Education Event for the “Inside Washington Seminar” Young Presidents’ Organization, 2013 International Award for Best Education Event  Young Presidents’ Organization, 2015 and 2016 Named in \"Power 100: Washington's Most Influential\"  Washington Life Magazine George Washington University George Washington University Law School Creighton University Creighton University School of Law Supreme Court of the United States District of Columbia Nebraska American Bar Association District of Columbia Bar Association Nebraska State Bar Association Executive Roundtable of the RGA YPO Gold, Northeast Regional Board of Directors, 2015-2016 YPO Gold, U.S. Capital Chapter, chair, 2015-2016 YPO, U.S. Capital Chapter, chair, 2008-2009 Represented many U.S. clients before foreign executive branch agencies in the Americas. Represents clients in the federal regulatory healthcare space at FDA, CMS and HHS. Represented client interests before the House and Senate Committees and Subcommittees.","searchable_name":"Steven M. Kupka (Steve)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":444364,"version":1,"owner_type":"Person","owner_id":5488,"payload":{"bio":"\u003cp\u003eDara Kurlancheek is a first chair trial attorney with nearly 20 years of experience in complex patent litigation. A registered patent attorney with a degree in electrical engineering, Dara has built a reputation for managing high-stakes cases across the financial services, technology, pharmaceutical and airline industries. Over her career, Dara has had significant victories on both sides of the aisle, having won tens of millions of dollars for clients and also obtaining a complete jury verdict defending against a $2.3 billion-dollar claim. Her litigation successes include district court trials, ITC cases, and arbitrations.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eThe technology in the cases that Dara has handled spans a wide range, including electronic banking systems, computer memory systems, mammography systems; customer service and payment acceptance technologies, video analytics, bladder cancer treatments, sonar imaging systems, aviation weather detection and navigation systems; computer systems for backup of internet-based data processing.\u003c/p\u003e\n\u003cp\u003eShe also advises on international and domestic disputes involving patent licensing, trade secrets, contract breaches, and unfair competition. Dara regularly counsels on issues like trade secret protection, non-compete agreements, and franchise or third-party contract disputes.\u003c/p\u003e\n\u003cp\u003eDara previously served as Deputy Chair of King \u0026amp; Spalding's Intellectual Property team and is a recurring guest lecturer at The Pennsylvania State University Smeal College of Business.\u003c/p\u003e","slug":"dara-kurlancheek","email":"dkurlancheek@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cem\u003e\u003cstrong\u003eCapital Security Systems Corporation v. CapitalOne and ABNB Financial Services\u0026nbsp;\u003c/strong\u003e\u003c/em\u003e(Eastern District of Virginia);\u0026nbsp;\u003cem\u003e\u003cstrong\u003ev. SunTrust and NCR Corporation\u003c/strong\u003e\u003c/em\u003e\u0026nbsp;(Northern District of Georgia). Counsel in matter involving the use of ATM\u0026rsquo;s and specifically hardware and software functionality allowing customers to make deposits via an ATM without the need of an envelope or other documents. The trial team obtained an extremely favorable Markman ruling resulting in plaintiff conceding non-infringement, and also successfully invalidated several of the asserted claims. On appeal, The Federal Circuit issued a Rule 36 affirmance on the non-infringement/Markman appeal, which yielded a complete win on non-infringement for the team.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eEcoServices, LLC v. Certified Aviation Services, LLC\u003c/em\u003e\u003c/strong\u003e\u0026nbsp;(Central District of California). Counsel for the defendant, Certified Aviation Services, LLC, in a patent infringement matter between competitors in the aircraft engine wash industry. The patents involve specific features and technical measurements for use of atomized spray, and also directed to the technical features and use of the system for detecting engine type utilizing specific detection related technology.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eNCR Corporation v. Pendum, LLC et al\u003c/em\u003e\u003c/strong\u003e\u0026nbsp;(Northern District of Georgia). Representing NCR Corporation in the Northern District of Georgia in a trademark and copyright infringement and misappropriation of trade secrets matter against Pendum, LLC and Burroughs, Inc.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eAnuwave, LLC v. Jacksboro National Bancshares, Inc. et al\u003c/em\u003e\u003c/strong\u003e\u0026nbsp;(Eastern District of Texas). Defended Jacksonboro National Bancshares, Inc. in a patent infringement matter against Anuwave LLC in which alleged infringement of a patent that allowed users to receive bank services via SMS messages.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eSt. Isidore Research, LLC v. LegacyTexas Group, Inc. et al\u003c/em\u003e\u003c/strong\u003e\u0026nbsp;(Eastern District of Texas). Represented LegacyTexas Group in the Eastern District of Texas in a patent infringement matter involving systems and methods for verifying, authenticating, and providing notification of a transaction, such as a commercial or financial transaction.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eOlivistar LLC. Regions Bank\u003c/em\u003e\u003c/strong\u003e\u003cem\u003e\u0026nbsp;\u003c/em\u003e(Eastern District of Texas). Represented Regions Bank in a patent infringement matter involving cloud storage systems.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003ebuySAFE Inc. v. Google Inc\u003c/em\u003e\u003c/strong\u003e. Represented Google against buySAFE\u0026rsquo;s claims of patent infringement. The technology includes online transaction performance guarantees. Successfully argued the claims covered unpatentable subject matter under 35 USC \u0026sect; 101 and won judgment on the pleadings pursuant to Federal Rule of Civil Procedure 12(c).\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eLoyalty Conversion Systems Corporation v. American Airlines, Inc\u003c/em\u003e\u003c/strong\u003e\u003cspan style=\"font-weight: normal !msorm; font-style: normal !msorm;\"\u003e\u003cstrong\u003e\u003cem\u003e. \u003c/em\u003e\u003c/strong\u003e\u003c/span\u003e\u003cstrong\u003e\u003cem\u003eet al.\u003c/em\u003e\u003c/strong\u003e\u0026nbsp;(Eastern District of Texas). Counsel for American Airlines, United Airlines, US Airways, Frontier Airlines and other major international airlines against Loyalty Conversion Systems Corporation in a patent infringement case filed in the Eastern District of Texas. The technology included converting loyalty points into other forms of credits and/or currency for purchase of good and/or services. Successfully argued that the claims covered unpatentable subject matter under 35 USC 101 and won judgment on the pleadings pursuant to Federal Rule of Civil Procedure 12(c). In addition, filed two Covered Business Method Patent Review Petitions that were instituted on 101 grounds.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGemalto, Inc. v. Merchant Customer Exchange\u003c/em\u003e\u003c/strong\u003e. Commercial arbitration in which our client claimed improper termination of a service contract for the provision of a mobile payment platform. After a week-long arbitration before a three-judge panel, won $45.8 million (including attorney fees) for improper termination in a complete victory for our client.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eBrilliant Optical Solutions v. Google\u003c/em\u003e\u003c/strong\u003e. Represented Google Fiber, Inc. in a patent infringement case filed in the Western District of Missouri where the Google Fiber System has been accused of infringement.\u0026nbsp;\u003cem\u003eBrilliant Optical Solutions, LLC v. Google Inc\u003c/em\u003e., No. 4:13-cv-00356 (W.D. Minn., filed April 10, 2013).\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eAeritas LLC v. US Airways\u003c/em\u003e\u003c/strong\u003e. Defended multiple major airlines in actions brought in the District of Delaware alleging infringement of the use of an electronic mobile boarding pass to gain entry on a flight.\u0026nbsp;\u003cem\u003eAeritas, LLC v. \u003c/em\u003e\u003cem\u003eUS Airways Group, Inc. et al\u003c/em\u003e., No. 1:11-cv-01267 (D. Del., filed December 21, 2011).\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eCreateads v. Web.com, Network Solutions and Register.com\u003c/em\u003e\u003c/strong\u003e. Represented Web.com et. al in a patent infringement case in the D. of Delaware involving web development technology.\u0026nbsp;\u003cem\u003eCreateAds LLC v. Web.com Group Inc., et al.\u003c/em\u003e, No. 1:12-cv-01612 (D. Del., filed November 29, 2012).\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eCreateads v. Media Temple\u003c/em\u003e\u003c/strong\u003e. Defended Media Temple in a patent infringement case in the D. of Delaware involving web development technology.\u0026nbsp;\u003cem\u003eCreateAds LLC v. Media Temple, Inc\u003c/em\u003e., No. 1:13-cv-00115 (D. Del., filed January 18, 2013).\u003c/p\u003e","\u003cp\u003eSuccessfully obtained a judgment of priority on behalf of client in a patent interference related to computers that use point-to-point links to transfer data between a memory controller and buffered memory. (B.P.A.I. Decision 2010).\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":13,"guid":"13.capabilities","index":1,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":2,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":3,"source":"capabilities"},{"id":1202,"guid":"1202.smart_tags","index":4,"source":"smartTags"},{"id":1240,"guid":"1240.smart_tags","index":5,"source":"smartTags"},{"id":107,"guid":"107.capabilities","index":6,"source":"capabilities"},{"id":765,"guid":"765.smart_tags","index":7,"source":"smartTags"},{"id":1270,"guid":"1270.smart_tags","index":8,"source":"smartTags"},{"id":1409,"guid":"1409.smart_tags","index":9,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Kurlancheek","nick_name":"Dara","clerkships":[],"first_name":"Dara","title_rank":9999,"updated_by":202,"law_schools":[{"id":734,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2008-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"M.","name_suffix":"","recognitions":[{"title":"Named Washington, D.C., “Rising Star”","detail":"Super Lawyers, 2015-2019"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eDara Kurlancheek is a first chair trial attorney with nearly 20 years of experience in complex patent litigation. A registered patent attorney with a degree in electrical engineering, Dara has built a reputation for managing high-stakes cases across the financial services, technology, pharmaceutical and airline industries. Over her career, Dara has had significant victories on both sides of the aisle, having won tens of millions of dollars for clients and also obtaining a complete jury verdict defending against a $2.3 billion-dollar claim. Her litigation successes include district court trials, ITC cases, and arbitrations.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eThe technology in the cases that Dara has handled spans a wide range, including electronic banking systems, computer memory systems, mammography systems; customer service and payment acceptance technologies, video analytics, bladder cancer treatments, sonar imaging systems, aviation weather detection and navigation systems; computer systems for backup of internet-based data processing.\u003c/p\u003e\n\u003cp\u003eShe also advises on international and domestic disputes involving patent licensing, trade secrets, contract breaches, and unfair competition. Dara regularly counsels on issues like trade secret protection, non-compete agreements, and franchise or third-party contract disputes.\u003c/p\u003e\n\u003cp\u003eDara previously served as Deputy Chair of King \u0026amp; Spalding's Intellectual Property team and is a recurring guest lecturer at The Pennsylvania State University Smeal College of Business.\u003c/p\u003e","matters":["\u003cp\u003e\u003cem\u003e\u003cstrong\u003eCapital Security Systems Corporation v. CapitalOne and ABNB Financial Services\u0026nbsp;\u003c/strong\u003e\u003c/em\u003e(Eastern District of Virginia);\u0026nbsp;\u003cem\u003e\u003cstrong\u003ev. SunTrust and NCR Corporation\u003c/strong\u003e\u003c/em\u003e\u0026nbsp;(Northern District of Georgia). Counsel in matter involving the use of ATM\u0026rsquo;s and specifically hardware and software functionality allowing customers to make deposits via an ATM without the need of an envelope or other documents. The trial team obtained an extremely favorable Markman ruling resulting in plaintiff conceding non-infringement, and also successfully invalidated several of the asserted claims. On appeal, The Federal Circuit issued a Rule 36 affirmance on the non-infringement/Markman appeal, which yielded a complete win on non-infringement for the team.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eEcoServices, LLC v. Certified Aviation Services, LLC\u003c/em\u003e\u003c/strong\u003e\u0026nbsp;(Central District of California). Counsel for the defendant, Certified Aviation Services, LLC, in a patent infringement matter between competitors in the aircraft engine wash industry. The patents involve specific features and technical measurements for use of atomized spray, and also directed to the technical features and use of the system for detecting engine type utilizing specific detection related technology.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eNCR Corporation v. Pendum, LLC et al\u003c/em\u003e\u003c/strong\u003e\u0026nbsp;(Northern District of Georgia). Representing NCR Corporation in the Northern District of Georgia in a trademark and copyright infringement and misappropriation of trade secrets matter against Pendum, LLC and Burroughs, Inc.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eAnuwave, LLC v. Jacksboro National Bancshares, Inc. et al\u003c/em\u003e\u003c/strong\u003e\u0026nbsp;(Eastern District of Texas). Defended Jacksonboro National Bancshares, Inc. in a patent infringement matter against Anuwave LLC in which alleged infringement of a patent that allowed users to receive bank services via SMS messages.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eSt. Isidore Research, LLC v. LegacyTexas Group, Inc. et al\u003c/em\u003e\u003c/strong\u003e\u0026nbsp;(Eastern District of Texas). Represented LegacyTexas Group in the Eastern District of Texas in a patent infringement matter involving systems and methods for verifying, authenticating, and providing notification of a transaction, such as a commercial or financial transaction.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eOlivistar LLC. Regions Bank\u003c/em\u003e\u003c/strong\u003e\u003cem\u003e\u0026nbsp;\u003c/em\u003e(Eastern District of Texas). Represented Regions Bank in a patent infringement matter involving cloud storage systems.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003ebuySAFE Inc. v. Google Inc\u003c/em\u003e\u003c/strong\u003e. Represented Google against buySAFE\u0026rsquo;s claims of patent infringement. The technology includes online transaction performance guarantees. Successfully argued the claims covered unpatentable subject matter under 35 USC \u0026sect; 101 and won judgment on the pleadings pursuant to Federal Rule of Civil Procedure 12(c).\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eLoyalty Conversion Systems Corporation v. American Airlines, Inc\u003c/em\u003e\u003c/strong\u003e\u003cspan style=\"font-weight: normal !msorm; font-style: normal !msorm;\"\u003e\u003cstrong\u003e\u003cem\u003e. \u003c/em\u003e\u003c/strong\u003e\u003c/span\u003e\u003cstrong\u003e\u003cem\u003eet al.\u003c/em\u003e\u003c/strong\u003e\u0026nbsp;(Eastern District of Texas). Counsel for American Airlines, United Airlines, US Airways, Frontier Airlines and other major international airlines against Loyalty Conversion Systems Corporation in a patent infringement case filed in the Eastern District of Texas. The technology included converting loyalty points into other forms of credits and/or currency for purchase of good and/or services. Successfully argued that the claims covered unpatentable subject matter under 35 USC 101 and won judgment on the pleadings pursuant to Federal Rule of Civil Procedure 12(c). In addition, filed two Covered Business Method Patent Review Petitions that were instituted on 101 grounds.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGemalto, Inc. v. Merchant Customer Exchange\u003c/em\u003e\u003c/strong\u003e. Commercial arbitration in which our client claimed improper termination of a service contract for the provision of a mobile payment platform. After a week-long arbitration before a three-judge panel, won $45.8 million (including attorney fees) for improper termination in a complete victory for our client.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eBrilliant Optical Solutions v. Google\u003c/em\u003e\u003c/strong\u003e. Represented Google Fiber, Inc. in a patent infringement case filed in the Western District of Missouri where the Google Fiber System has been accused of infringement.\u0026nbsp;\u003cem\u003eBrilliant Optical Solutions, LLC v. Google Inc\u003c/em\u003e., No. 4:13-cv-00356 (W.D. Minn., filed April 10, 2013).\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eAeritas LLC v. US Airways\u003c/em\u003e\u003c/strong\u003e. Defended multiple major airlines in actions brought in the District of Delaware alleging infringement of the use of an electronic mobile boarding pass to gain entry on a flight.\u0026nbsp;\u003cem\u003eAeritas, LLC v. \u003c/em\u003e\u003cem\u003eUS Airways Group, Inc. et al\u003c/em\u003e., No. 1:11-cv-01267 (D. Del., filed December 21, 2011).\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eCreateads v. Web.com, Network Solutions and Register.com\u003c/em\u003e\u003c/strong\u003e. Represented Web.com et. al in a patent infringement case in the D. of Delaware involving web development technology.\u0026nbsp;\u003cem\u003eCreateAds LLC v. Web.com Group Inc., et al.\u003c/em\u003e, No. 1:12-cv-01612 (D. Del., filed November 29, 2012).\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eCreateads v. Media Temple\u003c/em\u003e\u003c/strong\u003e. Defended Media Temple in a patent infringement case in the D. of Delaware involving web development technology.\u0026nbsp;\u003cem\u003eCreateAds LLC v. Media Temple, Inc\u003c/em\u003e., No. 1:13-cv-00115 (D. Del., filed January 18, 2013).\u003c/p\u003e","\u003cp\u003eSuccessfully obtained a judgment of priority on behalf of client in a patent interference related to computers that use point-to-point links to transfer data between a memory controller and buffered memory. (B.P.A.I. Decision 2010).\u003c/p\u003e"],"recognitions":[{"title":"Named Washington, D.C., “Rising Star”","detail":"Super Lawyers, 2015-2019"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10852}]},"capability_group_id":3},"created_at":"2025-12-17T16:33:18.000Z","updated_at":"2025-12-17T16:33:18.000Z","searchable_text":"Kurlancheek{{ FIELD }}{:title=\u0026gt;\"Named Washington, D.C., “Rising Star”\", :detail=\u0026gt;\"Super Lawyers, 2015-2019\"}{{ FIELD }}Capital Security Systems Corporation v. CapitalOne and ABNB Financial Services (Eastern District of Virginia); v. SunTrust and NCR Corporation (Northern District of Georgia). Counsel in matter involving the use of ATM’s and specifically hardware and software functionality allowing customers to make deposits via an ATM without the need of an envelope or other documents. The trial team obtained an extremely favorable Markman ruling resulting in plaintiff conceding non-infringement, and also successfully invalidated several of the asserted claims. On appeal, The Federal Circuit issued a Rule 36 affirmance on the non-infringement/Markman appeal, which yielded a complete win on non-infringement for the team.{{ FIELD }}EcoServices, LLC v. Certified Aviation Services, LLC (Central District of California). Counsel for the defendant, Certified Aviation Services, LLC, in a patent infringement matter between competitors in the aircraft engine wash industry. The patents involve specific features and technical measurements for use of atomized spray, and also directed to the technical features and use of the system for detecting engine type utilizing specific detection related technology.{{ FIELD }}NCR Corporation v. Pendum, LLC et al (Northern District of Georgia). Representing NCR Corporation in the Northern District of Georgia in a trademark and copyright infringement and misappropriation of trade secrets matter against Pendum, LLC and Burroughs, Inc.{{ FIELD }}Anuwave, LLC v. Jacksboro National Bancshares, Inc. et al (Eastern District of Texas). Defended Jacksonboro National Bancshares, Inc. in a patent infringement matter against Anuwave LLC in which alleged infringement of a patent that allowed users to receive bank services via SMS messages.{{ FIELD }}St. Isidore Research, LLC v. LegacyTexas Group, Inc. et al (Eastern District of Texas). Represented LegacyTexas Group in the Eastern District of Texas in a patent infringement matter involving systems and methods for verifying, authenticating, and providing notification of a transaction, such as a commercial or financial transaction.{{ FIELD }}Olivistar LLC. Regions Bank (Eastern District of Texas). Represented Regions Bank in a patent infringement matter involving cloud storage systems.{{ FIELD }}buySAFE Inc. v. Google Inc. Represented Google against buySAFE’s claims of patent infringement. The technology includes online transaction performance guarantees. Successfully argued the claims covered unpatentable subject matter under 35 USC § 101 and won judgment on the pleadings pursuant to Federal Rule of Civil Procedure 12(c).{{ FIELD }}Loyalty Conversion Systems Corporation v. American Airlines, Inc. et al. (Eastern District of Texas). Counsel for American Airlines, United Airlines, US Airways, Frontier Airlines and other major international airlines against Loyalty Conversion Systems Corporation in a patent infringement case filed in the Eastern District of Texas. The technology included converting loyalty points into other forms of credits and/or currency for purchase of good and/or services. Successfully argued that the claims covered unpatentable subject matter under 35 USC 101 and won judgment on the pleadings pursuant to Federal Rule of Civil Procedure 12(c). In addition, filed two Covered Business Method Patent Review Petitions that were instituted on 101 grounds.{{ FIELD }}Gemalto, Inc. v. Merchant Customer Exchange. Commercial arbitration in which our client claimed improper termination of a service contract for the provision of a mobile payment platform. After a week-long arbitration before a three-judge panel, won $45.8 million (including attorney fees) for improper termination in a complete victory for our client.{{ FIELD }}Brilliant Optical Solutions v. Google. Represented Google Fiber, Inc. in a patent infringement case filed in the Western District of Missouri where the Google Fiber System has been accused of infringement. Brilliant Optical Solutions, LLC v. Google Inc., No. 4:13-cv-00356 (W.D. Minn., filed April 10, 2013).{{ FIELD }}Aeritas LLC v. US Airways. Defended multiple major airlines in actions brought in the District of Delaware alleging infringement of the use of an electronic mobile boarding pass to gain entry on a flight. Aeritas, LLC v. US Airways Group, Inc. et al., No. 1:11-cv-01267 (D. Del., filed December 21, 2011).{{ FIELD }}Createads v. Web.com, Network Solutions and Register.com. Represented Web.com et. al in a patent infringement case in the D. of Delaware involving web development technology. CreateAds LLC v. Web.com Group Inc., et al., No. 1:12-cv-01612 (D. Del., filed November 29, 2012).{{ FIELD }}Createads v. Media Temple. Defended Media Temple in a patent infringement case in the D. of Delaware involving web development technology. CreateAds LLC v. Media Temple, Inc., No. 1:13-cv-00115 (D. Del., filed January 18, 2013).{{ FIELD }}Successfully obtained a judgment of priority on behalf of client in a patent interference related to computers that use point-to-point links to transfer data between a memory controller and buffered memory. (B.P.A.I. Decision 2010).{{ FIELD }}Dara Kurlancheek is a first chair trial attorney with nearly 20 years of experience in complex patent litigation. A registered patent attorney with a degree in electrical engineering, Dara has built a reputation for managing high-stakes cases across the financial services, technology, pharmaceutical and airline industries. Over her career, Dara has had significant victories on both sides of the aisle, having won tens of millions of dollars for clients and also obtaining a complete jury verdict defending against a $2.3 billion-dollar claim. Her litigation successes include district court trials, ITC cases, and arbitrations.\nThe technology in the cases that Dara has handled spans a wide range, including electronic banking systems, computer memory systems, mammography systems; customer service and payment acceptance technologies, video analytics, bladder cancer treatments, sonar imaging systems, aviation weather detection and navigation systems; computer systems for backup of internet-based data processing.\nShe also advises on international and domestic disputes involving patent licensing, trade secrets, contract breaches, and unfair competition. Dara regularly counsels on issues like trade secret protection, non-compete agreements, and franchise or third-party contract disputes.\nDara previously served as Deputy Chair of King \u0026amp; Spalding's Intellectual Property team and is a recurring guest lecturer at The Pennsylvania State University Smeal College of Business. Partner Named Washington, D.C., “Rising Star” Super Lawyers, 2015-2019 Pennsylvania State University Pennsylvania State University, Dickinson School of Law Franklin Pierce College Franklin Pierce Law Center U.S. Court of Appeals for the Federal Circuit U.S. Patent and Trademark Office U.S. District Court for the Eastern District of New York U.S. District Court for the Southern District of New York U.S. District Court for the Eastern District of Texas District of Columbia New York Capital Security Systems Corporation v. CapitalOne and ABNB Financial Services (Eastern District of Virginia); v. SunTrust and NCR Corporation (Northern District of Georgia). Counsel in matter involving the use of ATM’s and specifically hardware and software functionality allowing customers to make deposits via an ATM without the need of an envelope or other documents. The trial team obtained an extremely favorable Markman ruling resulting in plaintiff conceding non-infringement, and also successfully invalidated several of the asserted claims. On appeal, The Federal Circuit issued a Rule 36 affirmance on the non-infringement/Markman appeal, which yielded a complete win on non-infringement for the team. EcoServices, LLC v. Certified Aviation Services, LLC (Central District of California). Counsel for the defendant, Certified Aviation Services, LLC, in a patent infringement matter between competitors in the aircraft engine wash industry. The patents involve specific features and technical measurements for use of atomized spray, and also directed to the technical features and use of the system for detecting engine type utilizing specific detection related technology. NCR Corporation v. Pendum, LLC et al (Northern District of Georgia). Representing NCR Corporation in the Northern District of Georgia in a trademark and copyright infringement and misappropriation of trade secrets matter against Pendum, LLC and Burroughs, Inc. Anuwave, LLC v. Jacksboro National Bancshares, Inc. et al (Eastern District of Texas). Defended Jacksonboro National Bancshares, Inc. in a patent infringement matter against Anuwave LLC in which alleged infringement of a patent that allowed users to receive bank services via SMS messages. St. Isidore Research, LLC v. LegacyTexas Group, Inc. et al (Eastern District of Texas). Represented LegacyTexas Group in the Eastern District of Texas in a patent infringement matter involving systems and methods for verifying, authenticating, and providing notification of a transaction, such as a commercial or financial transaction. Olivistar LLC. Regions Bank (Eastern District of Texas). Represented Regions Bank in a patent infringement matter involving cloud storage systems. buySAFE Inc. v. Google Inc. Represented Google against buySAFE’s claims of patent infringement. The technology includes online transaction performance guarantees. Successfully argued the claims covered unpatentable subject matter under 35 USC § 101 and won judgment on the pleadings pursuant to Federal Rule of Civil Procedure 12(c). Loyalty Conversion Systems Corporation v. American Airlines, Inc. et al. (Eastern District of Texas). Counsel for American Airlines, United Airlines, US Airways, Frontier Airlines and other major international airlines against Loyalty Conversion Systems Corporation in a patent infringement case filed in the Eastern District of Texas. The technology included converting loyalty points into other forms of credits and/or currency for purchase of good and/or services. Successfully argued that the claims covered unpatentable subject matter under 35 USC 101 and won judgment on the pleadings pursuant to Federal Rule of Civil Procedure 12(c). In addition, filed two Covered Business Method Patent Review Petitions that were instituted on 101 grounds. Gemalto, Inc. v. Merchant Customer Exchange. Commercial arbitration in which our client claimed improper termination of a service contract for the provision of a mobile payment platform. After a week-long arbitration before a three-judge panel, won $45.8 million (including attorney fees) for improper termination in a complete victory for our client. Brilliant Optical Solutions v. Google. Represented Google Fiber, Inc. in a patent infringement case filed in the Western District of Missouri where the Google Fiber System has been accused of infringement. Brilliant Optical Solutions, LLC v. Google Inc., No. 4:13-cv-00356 (W.D. Minn., filed April 10, 2013). Aeritas LLC v. US Airways. Defended multiple major airlines in actions brought in the District of Delaware alleging infringement of the use of an electronic mobile boarding pass to gain entry on a flight. Aeritas, LLC v. US Airways Group, Inc. et al., No. 1:11-cv-01267 (D. Del., filed December 21, 2011). Createads v. Web.com, Network Solutions and Register.com. Represented Web.com et. al in a patent infringement case in the D. of Delaware involving web development technology. CreateAds LLC v. Web.com Group Inc., et al., No. 1:12-cv-01612 (D. Del., filed November 29, 2012). Createads v. Media Temple. Defended Media Temple in a patent infringement case in the D. of Delaware involving web development technology. CreateAds LLC v. Media Temple, Inc., No. 1:13-cv-00115 (D. Del., filed January 18, 2013). Successfully obtained a judgment of priority on behalf of client in a patent interference related to computers that use point-to-point links to transfer data between a memory controller and buffered memory. (B.P.A.I. Decision 2010).","searchable_name":"Dara M. Kurlancheek","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426527,"version":1,"owner_type":"Person","owner_id":4045,"payload":{"bio":"\u003cp\u003eChristina Kung is a Senior Associate in the Special Matters and Government Investigations practice. She focuses her practice on government investigations, white-collar criminal defense, and related civil litigation. Christina has experience defending individuals and corporations in matters related to various topics, including the False Claims Act, Foreign Agents Registration Act, the Anti-Kickback Statute, whistleblower litigation, and fraud investigations. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003eChristina graduated from The George Washington University Law School, where she was a member of \u003cem\u003eThe George Washington Law Review\u003c/em\u003e. She earned her B.A. in International Development Studies and Sociology from the University of California, Los Angeles. \u0026nbsp;\u003c/p\u003e","slug":"christina-kung","email":"ckung@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":1,"source":"smartTags"},{"id":1241,"guid":"1241.smart_tags","index":2,"source":"smartTags"}],"is_active":true,"last_name":"Kung","nick_name":"Christina","clerkships":[],"first_name":"Christina","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":75,"translated_fields":{"en":{"bio":"\u003cp\u003eChristina Kung is a Senior Associate in the Special Matters and Government Investigations practice. She focuses her practice on government investigations, white-collar criminal defense, and related civil litigation. Christina has experience defending individuals and corporations in matters related to various topics, including the False Claims Act, Foreign Agents Registration Act, the Anti-Kickback Statute, whistleblower litigation, and fraud investigations. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003eChristina graduated from The George Washington University Law School, where she was a member of \u003cem\u003eThe George Washington Law Review\u003c/em\u003e. She earned her B.A. in International Development Studies and Sociology from the University of California, Los Angeles. \u0026nbsp;\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10002}]},"capability_group_id":null},"created_at":"2025-05-26T04:54:20.000Z","updated_at":"2025-05-26T04:54:20.000Z","searchable_text":"Kung{{ FIELD }}Christina Kung is a Senior Associate in the Special Matters and Government Investigations practice. She focuses her practice on government investigations, white-collar criminal defense, and related civil litigation. Christina has experience defending individuals and corporations in matters related to various topics, including the False Claims Act, Foreign Agents Registration Act, the Anti-Kickback Statute, whistleblower litigation, and fraud investigations.  \nChristina graduated from The George Washington University Law School, where she was a member of The George Washington Law Review. She earned her B.A. in International Development Studies and Sociology from the University of California, Los Angeles.   Senior Associate California District of Columbia","searchable_name":"Christina Kung","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":436447,"version":1,"owner_type":"Person","owner_id":5785,"payload":{"bio":"\u003cp\u003eLauren's practice focuses on securities enforcement, anti-corruption\u0026nbsp;investigations, internal investigations, compliance counseling,\u0026nbsp;white-collar criminal defense, and related civil litigation.\u0026nbsp;Lauren represents\u0026nbsp;clients\u0026nbsp;before the U.S. Securities and Exchange Commission and U.S. Department of Justice, as well as other domestic and international authorities.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eLauren graduated from the Georgetown University Law Center\u0026nbsp;and earned her M.A. and B.A. from the George Washington University. During law school, she was a Managing Editor for the\u0026nbsp;\u003cem\u003eAmerican Criminal Law Review\u003c/em\u003e,\u0026nbsp;a member of the Appellate Advocacy Division of Barristers' Council, and a student attorney for the International Women's Human Rights Clinic.\u003c/p\u003e\n\u003cp\u003eLauren has interned for the Division of Enforcement and Division of Examinations at the U.S. Securities and Exchange Commission, the Money Laundering and Asset Recovery Section at the U.S. Department of Justice, the U.S. Attorney's Office for the District of Maryland, the Honorable Timothy J. Kelly, and the Office of General Counsel at\u0026nbsp;the National Archives and Records Administration.\u003c/p\u003e","slug":"lauren-konczos","email":"lkonczos@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":20,"guid":"20.capabilities","index":0,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":126,"guid":"126.capabilities","index":3,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":4,"source":"capabilities"},{"id":1188,"guid":"1188.smart_tags","index":5,"source":"smartTags"},{"id":766,"guid":"766.smart_tags","index":6,"source":"smartTags"},{"id":1199,"guid":"1199.smart_tags","index":7,"source":"smartTags"},{"id":952,"guid":"952.smart_tags","index":8,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":9,"source":"smartTags"},{"id":923,"guid":"923.smart_tags","index":10,"source":"smartTags"},{"id":1184,"guid":"1184.smart_tags","index":11,"source":"smartTags"},{"id":765,"guid":"765.smart_tags","index":12,"source":"smartTags"},{"id":5,"guid":"5.smart_tags","index":13,"source":"smartTags"}],"is_active":true,"last_name":"Konczos","nick_name":"Lauren","clerkships":[{"name":"Intern, The Honorable Timothy J. Kelly, U.S. District Court for the District of Columbia","years_held":"2020 - 2020"}],"first_name":"Lauren","title_rank":9999,"updated_by":101,"law_schools":[{"id":755,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2021-01-01 00:00:00 UTC"},"order":2,"pin_order":null,"pin_expiration":null}],"middle_name":"O.","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/laurenkonczos/","seodescription":null,"primary_title_id":2,"translated_fields":{"en":{"bio":"\u003cp\u003eLauren's practice focuses on securities enforcement, anti-corruption\u0026nbsp;investigations, internal investigations, compliance counseling,\u0026nbsp;white-collar criminal defense, and related civil litigation.\u0026nbsp;Lauren represents\u0026nbsp;clients\u0026nbsp;before the U.S. Securities and Exchange Commission and U.S. Department of Justice, as well as other domestic and international authorities.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eLauren graduated from the Georgetown University Law Center\u0026nbsp;and earned her M.A. and B.A. from the George Washington University. During law school, she was a Managing Editor for the\u0026nbsp;\u003cem\u003eAmerican Criminal Law Review\u003c/em\u003e,\u0026nbsp;a member of the Appellate Advocacy Division of Barristers' Council, and a student attorney for the International Women's Human Rights Clinic.\u003c/p\u003e\n\u003cp\u003eLauren has interned for the Division of Enforcement and Division of Examinations at the U.S. Securities and Exchange Commission, the Money Laundering and Asset Recovery Section at the U.S. Department of Justice, the U.S. Attorney's Office for the District of Maryland, the Honorable Timothy J. Kelly, and the Office of General Counsel at\u0026nbsp;the National Archives and Records Administration.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9977}]},"capability_group_id":2},"created_at":"2025-09-02T04:54:31.000Z","updated_at":"2025-09-02T04:54:31.000Z","searchable_text":"Konczos{{ FIELD }}Lauren's practice focuses on securities enforcement, anti-corruption investigations, internal investigations, compliance counseling, white-collar criminal defense, and related civil litigation. Lauren represents clients before the U.S. Securities and Exchange Commission and U.S. Department of Justice, as well as other domestic and international authorities.\nLauren graduated from the Georgetown University Law Center and earned her M.A. and B.A. from the George Washington University. During law school, she was a Managing Editor for the American Criminal Law Review, a member of the Appellate Advocacy Division of Barristers' Council, and a student attorney for the International Women's Human Rights Clinic.\nLauren has interned for the Division of Enforcement and Division of Examinations at the U.S. Securities and Exchange Commission, the Money Laundering and Asset Recovery Section at the U.S. Department of Justice, the U.S. Attorney's Office for the District of Maryland, the Honorable Timothy J. Kelly, and the Office of General Counsel at the National Archives and Records Administration. Associate George Washington University  George Washington University  Georgetown University Georgetown University Law Center George Washington University  District of Columbia Women's White Collar Defense Association Intern, The Honorable Timothy J. Kelly, U.S. District Court for the District of Columbia","searchable_name":"Lauren O. Konczos","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":444044,"version":1,"owner_type":"Person","owner_id":6688,"payload":{"bio":"\u003cp\u003eBrooke Kopel is an Associate in King \u0026amp; Spalding's Business Litigation practice group. She represents clients in\u0026nbsp;a wide range of complex commercial disputes, including intellectual property disputes, breach of contract claims, mass torts, consumer fraud, false advertising, and unfair competition.\u003c/p\u003e\n\u003cp\u003e*Admitted only in California;\u0026nbsp;practice supervised by D.C. Bar Members\u003c/p\u003e","slug":"brooke-kopel","email":"bkopel@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":3612}]},"expertise":[{"id":5,"guid":"5.capabilities","index":0,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":1,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":2,"source":"capabilities"},{"id":105,"guid":"105.capabilities","index":3,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":4,"source":"capabilities"}],"is_active":true,"last_name":"Kopel","nick_name":"Brooke","clerkships":[],"first_name":"Brooke","title_rank":9999,"updated_by":202,"law_schools":[{"id":3051,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2022-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":"Brooke Kopel is a lawyer of our Business Litigation Practice Group. Read more about her.","primary_title_id":2,"translated_fields":{"en":{"bio":"\u003cp\u003eBrooke Kopel is an Associate in King \u0026amp; Spalding's Business Litigation practice group. She represents clients in\u0026nbsp;a wide range of complex commercial disputes, including intellectual property disputes, breach of contract claims, mass torts, consumer fraud, false advertising, and unfair competition.\u003c/p\u003e\n\u003cp\u003e*Admitted only in California;\u0026nbsp;practice supervised by D.C. Bar Members\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13248}]},"capability_group_id":3},"created_at":"2025-12-08T20:29:42.000Z","updated_at":"2025-12-08T20:29:42.000Z","searchable_text":"Kopel{{ FIELD }}Brooke Kopel is an Associate in King \u0026amp; Spalding's Business Litigation practice group. She represents clients in a wide range of complex commercial disputes, including intellectual property disputes, breach of contract claims, mass torts, consumer fraud, false advertising, and unfair competition.\n*Admitted only in California; practice supervised by D.C. Bar Members Brooke Kopel lawyer Associate University of California-Santa Barbara  University of Southern California Gould School of Law University of Southern California Gould School of Law California","searchable_name":"Brooke Kopel","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null}]}}